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1. INTRODUCTION 
 
 
 Siddha is the most ancient Indian medical science of life.The Siddha system of 
medicine is a scientifically unique art of healing. It is an integrated part of Indian system of 
medicine which is very potent. The siddha system of medicine is one among the foremost of 
all other medical systems of the world. 
 
 Siddha system of medicine   is believed  to be  developed  by the 
Siddhars, the ancient supernatural Spiritual Saints of India and the Siddha System is believed 
to be handed over to the Siddhars  by the Hindu God Lord Shiva and Goddess Parvathi. So 
are the siddhars ,the  followers of Lord Shiva. 
    
 According to the scriptures ,there were 18 principal siddhars. Of these 18, sage 
Agasthiyar is believed to be the father  of siddha medicine.. 
 
 Siddhars through their great powers like Attamasiddhikal and through immense 
prayers realised  the fact that soul which is ultimately  a part of the supreme is like a drop of 
water from sea. 
 
Children are the hands by which we take hold of heaven. 
                                                                     - Henry Ward Beecher   
''§¿¡Â¢ø¨Ä ¦¿¡ÊÂ¢ø¨Ä 
§¿¡ì¸¡ð¼¡ø º¢ÚÅÂ¾¢ø  
Á¡öó¾¢ÎÅ¡÷ Üð¼Á¢ø¨Ä 
Å¡úì¨¸Â¢§Ä âÃ½Á¡öò  
§¾¡öó¾¢ð¼¡÷ ¾¡ÁýÈ£ò 
ÐïÍÀÅ÷ Â¡ÕÁ¢ø¨Ä''. 
    þì¸É¨Å   ¿ÉÅ¡ì¸ ¯ûÇ  Ð¨È§Â ÌÆó¨¾ ÁÕòÐÅòÐ¨È. 
  
  Ascaris lumbricoides is an intestinal roundworm is one of the most common 
helminthic human infections worldwide.It is estimated that more than 1.4 billion 
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people are infected with Ascaris lumbricoides representing 25% of the world 
population. 
  A number of features account for its high prevalence including a ubiquitous 
distribution,indigestible of viable ova, shed by infected humans on humid and shady 
soil and that overcrowded living conditions increase the likelihood of faecal-oral 
transmission of infection. It is an infection of intestinal tract  caused by the adult Ascaris 
lumbricoides and  clinically  manifested  by  vague  symptoms  of  abdominal pain, nausea, 
anorexia and disturbed sleep with grinding teeth. Live worms are passed in stools or through 
vomiting.Most of the clinical features of KUDAL KIRUMI (Naakku Puchi Noi) described in 
Siddha literature are more or less similar to that of “Ascariasis”.  
Siddha system of medicine is very effective in the treatment of worm 
infestations.Among the other worms,Ascaris lumbricoides is one of the most common  
disease which affect children between the age group of 6-12.That's why I have selected the 
disease Naakku puchi noi(Ascariasis)as my dissertation topic. 
         In Brahmamuni karukadai soothiram 380, a Siddha formulatory text, there is a 
preparation named  Kudalkirumi choornam which is indicated for Kudal Kirumi (Naakku 
Puchi noi). This is a poly herbal formulation which  contain Anethum graveolens, Nigella 
sativa, Cuminum cyminum, Syzygium aromaticum and all the drugs are having antihelmintic 
activity. The drug Glycyrrhiza glabra having laxative activity and Coriander sativum have 
stomachic activity.  
Moreover the treatment is cost effective and the Kudal kirumi chooranam drug 
formulation has not undergone any clinical trial so far. Hence the author has selected Kudal 
kirumi chooranam to evaluate its efficacy in the treatment of Kudal kirumi .  
  Exhaustive study were carried out using a range of methods like biochemical, 
pharmacological and toxicological studies and clinical trials were conducted. 
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2. AIM AND OBJECTIVES 
The principle aim of the present study of Kudal Kirumi (Naakku Puchi noi) is  
v To evaluvate the efficacy of the Siddha drug Kudal Kirumi Chooranam in treating 
Kudal Kirumi (Naakku Puchi Noi)   
 
OBJECTIVES: 
 
v To evaluate the Bio-Chemical & Pharmacological analysis of the trial drug.  
 
v To collect and review the ideas mentioned in the ancient siddha literature about the 
disease - kudal kirumi(Naakku puchi noi) 
 
v To make the correlative study of the siddha and modern aspects of the disease. 
 
v To use the modern parameters in the investigation of the disease  to observe the 
progress of the patient. 
 
v To study the disease kudal kirumi(Naakku puchi noi)  on the basis of Thirithodam, 
Envagai thervugal, Neerkuri, Neikuri, Udalthathukal, Paruvakaalangal.  
 
v Finally, to create awareness among the public about Siddha treatment for Kudal 
Kirumi (Naakku Puchi noi).  
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3.1.1.fpUkp: 
 
 kdpj clk;gpy; rhjhuzkha; trpf;Fk; kw;Wk; Neha;fis cz;lhf;ff; $ba 
fhuzpfNs fpUkpfs; (m) G+r;rpfs;. 
 
ACCORDING TO T.V. SAMBASIVAM PILLAI DICTIONARY: 
 Worms / parasites of various shapes which germinate or grow in a living organism 
in the different parts of the human body. 
 
Flw;fpUkp 
 
,ay;: 
 Flypy; kpFe;j mstpy; fpUkpfs; cz;lhtjhy; tapw;Wtyp> ,rpT> kyf;fl;L 
(m) fopr;ry;> rUkj;jpy; mupg;G> the;jp> Ruk; Nghd;wditfis cz;lhf;Fk; Neha;. 
Three common varieties of worms infesting the human intestines are 
v ehlhg; G+r;rp - Tape worm 
v ehf;Fspg;G+r;rp - Round worm 
v fPiug;ghk;G - Thread worm 
 
NtW ngau;fs;: 
 
v tapw;Wf;fpUkp : tapw;Wg;GO - Parasites in the intestines. 
v ehf;Fspg;G+r;rp : ehf;Fspg;ghk;G - An intestinal worm -Ascaris 
 
v ehf;Fg;G+r;rp : Flw;GO> ,J clk;gpd; rj;jpdhy; capu; 
gpiof;Fk;. MfNt kdpjUf;F tapw;Wtyp> ,Og;G> Nrhif> Kjypa 
Neha;fSf;F ,JNt fhuzkhFk;. 
v ehfg; ghk;G : tapw;Wg; G+r;rp – Round worm, a parasite in the 
intestines namely Ascaris. 
v fpUkpr; nrhwp : GOf;fs; clk;gpDs; kPj;Njhy; topahf 
cl;NjhYf;Fs; GFtjhy; cz;lhFk; rfpf;f Kbahj nrhwp (m) jpdT. 
(Ascaris scabi) 
 
fpUkp Nuhfk;: 
ehf;Fg;G+r;rp> fPupg;G+r;rp> GO Kjypad kdpj clk;gpYs;s fUtp fuzq;fspy;                                                 
cw;gj;jpahfp> mt;tplj;jpYs;s jir> ,uj;jk; Kjypa jhJf;fisf; nfhz;L 
rPtpg;gjdhy;> mNef Neha;fs; Vw;gLk;. ,it mNef fhuzq;fis Kd;dpl;L 
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clk;gpYz;lhFk; gpj;jk; (m) rpNyl;Lk Mjpf;fj;jpdhy; gpwf;Fk;. ,jdhy; clk;G 
epwk; khwp> tapW typj;J> khu;G vLg;ghfj; Njhd;wp> ke;jk;> md;dj;JNtrk;> gpuik 
Kjypa Fwpfs; Vw;gLk;. Nrhif> kQ;rs; fhkhiy> ahidf;fhy;> gpuik> 
clk;gpisg;G> typg;G> Ruk;> <uy;typ Kjypad ,itfshy; cz;lhFk; 
Neha;fshFk;. 
 
fpUkpfs; cz;lhFk; tpjk; (G+r;rpfs; cz;lhFk; tpjk;) 
mff;fhuzk;> Gwf;fhuzq;fshy; cw;gj;jpahfpd;wd. 
 
mff;fhuzk;: 
clw;Fs; gf;Fthraj;ijAk;> FliyAk; gw;wp ngupa G+ehfk;> jl;ilGO> 
ney;Kid fpUkp (nfhf;fpg;GO) rd;df;fpUkp> ntz;ikf;fpUkp> nrk;ikf;fpUkp 
vd;w gytpjf; fpUkpfSk;> nfu;g;gg;GO> jpkpu;g;G+r;rp Kjypa fpUkpfSk; 
cz;lhFk;. ,it kyj;ij gw;wpAk; cz;lhFk; vd;gu;. kyk;> rpWePu;> ,uj;jk;> 
Rf;fpyk;> rPo;> rsp> tpau;it ,tw;wpYk; cw;gj;jpahtJz;L. 
 
Gwf;fhuzk;: 
,J clypd; mRj;jj;ijAk;> mOf;ifAk; fhuzkhff; nfhz;L cz;lhFk; 
vd;gu;. 
    - Neha; ehly; Neha; Kjy; ehly; jpul;L (g.vz;.353) 
 
3.1.2.fpUkp tiffs;: 
3.1.2.1.ACCORDING TO T.V. SAMBASIVAM PILLAI DICTIONARY: 
clk;gpw;Fs; fhzg;gLk; mNef tpjkhd GO (m) G+r;rpfs;: 
v ngUk; G+ehff; fpUkp - Nematode 
v ePu;g;ghk;Gf; fpUkp - An unknown kind 
v ney;Kidf; fpUkp - Hookworm 
v rd;dePsf;fpUkp - Filarial 
v mZf;fpUkp - Microbe 
v ntz; fpUkp - Thread worm 
v nrq;fpUkp - Red worm 
v me;ju;kyf; fpUkp - Worms of rectum. Oxyuris vermicularis 
v tl;lf;fpUkp - Round worm (Ascaris) 
v fhypy;yhf; fpUkp - Worms without legs for locomotion 
v #f;Fkf; fpUkp - Microzoan 
v Njhd;whf; fpUkp - Invisible worm 
v ,uj;jf; fpUkp - Germs of blood 
  
6 
 
v ePu;f;fpUkp - Water worms / germs 
v kQ;rl; fpUkp - Ochromyia 
v thw;fpUkp - Flagellated germ 
v kz;ilf; fpUkp - Worms in the head 
v #iuf; fpUkp - An unknown kind 
v RNuhzpjf; fpUkp - Germ cell 
v fUq;fpUkp - Black coloured germ 
v Jyf;fpUkp - Water worm 
v fzf;fpUkp - Germ responsible for ganam 
v jhJf;fpUkp - Germs concerned with vitality 
v tha;f;fpUkp - Worms found in the teeth, saliva etc 
v #jff; fpUkp - Germ cell 
v Gdf;fpUkp - An unknown kind 
v #iyf;fpUkp - Microbe of rheumatism/colic 
v Rf;fpyf; fpUkp - Spermatozoan 
v tapw;Wf;fpUkp - Germs in the stomach 
v Flw;fpUkp - Intestinal worms such as round worm etc 
v <uw;fpUkp - Liver flukes 
 
 
 
3.1.2.2.ACCORDING TO SIDDHA LITERATURE PILLAI PINI MARUTHUVAM: 
gps;isg;gpzp kUj;Jtk; vd;w Ehypy; fpUkpfis 27 tiffshfg; 
gpupf;fg;gl;Ls;sJ. ,tw;wpy; 19 tif fpUkpfSk>; 5 tif G+r;rpfSk;> 3 tif 
GOf;fSk; mlq;Fk 
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fpUkpfs; 
v ePu;g;ghk;Gf; fpUkp 
v ney;Kidf; fpUkp 
v rd;dePs fpUkp 
v mZf;fpUkp 
v ntz; fpUkp 
v nrq;fpUkp 
v me;ju;kyf;fpUkp 
v tl;lf;fpUkp 
v #l;rkf;fpUkp 
v Njhd;whf;fpUkp 
v ePu; fpUkp 
v kQ;rs; fpUkp 
v fUq;fpUkp 
v tha; fpUkp 
v tapw;Wf;fpUkp 
v Fly; fpUkp 
v <uy; fpUkp 
v fiz fpUkp 
v fhy; ,y;yh fpUkp 
 
G+r;rpfs;:  
v ehfg;G+r;rp 
v fPupg;G+r;rp 
v jpkpu;g;G+r;rp 
v gl;il G+r;rp 
v Ehy; G+r;rp 
 
GOf;fs;: 
v rhl;ilg;GOf;fs; 
v jhdg;GOf;fs; 
v kriug;GOf;fs; 
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3.12.3ACCORDING TO SIDDHA LITERATURE JEEVA RATCHAMIRDHAM: 
,jpy; 20 tifahd fpUkpfis gw;wpAk;> mitfs; trpf;Fk; 
,lNgjq;fspdhy; 4 tifahfTk; $wg;gl;Ls;sJ. mit: 
v ruPuj;jpd; Nky; ,Ug;gd 
v fgj;jpy; ,Ug;gd 
v ,uj;jj;jpy; ,Ug;gd 
v kyj;jpy; ,Ug;gd 
 
3.1.2.4ACCORDING TO BALAVAGADAM: 
,jpy; 3 tifahd fpUkpfis gw;wp $wg;gl;Ls;sJ. mit 
v kriug;GO 
v fPup g+r;rp 
v ehfg;g+r;rp 
 
fpUkpahy; cz;lhFk; Neha;fs;: 
31.2.5ACCORDING TO SIDDHA LITERATURE GURUNAADI: 
FUehb Ehypy; $wpAs;sgb fpUkpahy; tUk; Neha;fs; 
“fpUkpahy; te;jNjhlk; ngUfTz;L 
Nfl;fyjpd; gpuptjidf; fpukkhf 
nghUkptUk; tha;nty;yhq; fpUkpahNy 
GOf;fbNghy; fhZkJ fpUkpahNy 
nrUkptUk; gTj;jpuq;fs; fpUkpahNy 
Njfkjpy; Nrhiff; Fl;lq; fpUkpahNy 
JUkp tUQ; RNuhzpjk; fpUkpahNy 
#l;rKld; fpupifg;ghy; njhopy; nra;tPNu” 
     - FUehb 
nghUs;: 
fpUkpfs; ngUFk; nghOJ nghUky;> tha;T> GOf;fb> gTj;jpuk;> Nrhif> 
Fl;lk;> Rf;fpyg;gpuNkfk; Mfpa Nuhfq;fs; Vw;gLtJz;L. md;wpAk; Fd;kk;> 
faNuhfk;> Ruk;> ghz;L> ngUtapW> tplf;fug;ghd;> tplePu;r;#iy> Rf;fpyel;lk; 
,tw;why; jhJf;fs; nfl;Lj; jbg;Gz;lhFk;. mjpy; fpUkpAz;lha; fpUkpAltplePu; 
Njfnky;yhk; gutp FopFopaha; Gs;sp Gs;spaha; fpUkpAltplePuhy; Fl;lk;> 
tplfug;ghd; cw;gj;jpahFk;. 
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3.1.2.6.ACCORDING TO SIDDHA LITERATURE RATHNA SURUKKA NAADI: 
fpUkpahYz;lhFk; Neha;fs; Kf;fpakha; MW tif vd ,uj;jpdr; RUf;f 
ehbapy; $wg;gl;bUf;fpwJ. 
mit: 
1. tapw;Wg; nghUky; 
2. GOf;fb 
3. gTj;jpuk; 
4. Nrhif 
5. Fl;lk; 
6. Rf;fpy gpuNkfk; 
 
3.1.2.7.tl;lg;GOf;fs; (Round worm) 
,jd; ePsk; Rkhu; 20-35 nr.kP msT ,Uf;Fk;. ,jd; Kl;ilfs; fye;j 
czTg; nghUl;fis cz;gjhy; ,e;jg;G+r;rp guTfpd;wJ. ,jd; Kl;ilfs; 
 
bNahbdk; (Duodenum) vd;w Fly; gFjpapy; nghhpe;J GOf;fshf khWfpd;wd. 
,J rpW Flypy; KOtsu;r;rp ngWfpd;wJ. ,g;GO rpw;rpy rkaq;fspy; Mrdtha; 
Kjy; tha; tiu gazk; nra;Ak;. ,J jtwhf Rthrf; FoYf;Fr; nrd;Wtpl;lhy; 
kuzk; NehpLk;. ,t;tif tl;lg;GOf;fshy; tapw;Wtyp> Fly; milg;G> gpj;jghij 
milg;G> Cl;lr;rj;jpd;ik Nghd;w Neha;fs; cz;lhFk;. 
      Mjhuk;: gps;isg;gpzp kUj;Jtk; 
 
3.1.3tUk; top : 
3.1.3.1ACCORDING TO SIDDHA LITERATURE PILLAI PINI MARUTHUVAM: 
Jha;ikaw;w kyk; fye;j kz;zpy; tpisahLtjhYk;> kz;izj; 
jpz;gjhYk;> < nkha;j;j gz;lq;fs;> Jha;ikaw;w czT> fha;fwpfs;> goq;fs; 
Mfpatw;iw cz;gjhYk; kpFjpahd ,dpg;G tiffis cz;gjhYk;> 
nfl;Lg;Nghd gioa rhjk;> goq;fis cz;gjhYk;> gd;wp ,iwr;rp> khl;L 
,iwr;rpahYk;> rpy kPd; tiffis cz;gjhYk;> ehAld; neUf;fkhf 
goFtjhYk; Fly; fpUkpfs; cz;lhfpd;wd. NkYk; rpy G+r;rpfs; Mrd gFjpapy; 
Kl;il ,Lfpd;wd. Foe;ijahdJ Mrd gFjpapy; mhpf;Fk; NghJ ifapid 
itj;J Ruz;LfpwJ. gpwF mNj tpuiy thapy; itj;J #g;Gtjhy;, eff; 
fz;zpYs;s Kl;ilahdJ Foe;ijapd; czTg; ghijapy; nrd;W guTfpwJ. 
 
3.1.3.2.Flw;fpUkpapd; nghJf;FwpFzq;fs;: 
            ACCORDING TO SIDDHA MARUTHUVA NOI NAADAL PART I: 
cly; epwk; khwy;> Ruk;> tapw;Wtyp> khu;GNeha;> ntSg;G Neha;> Cjy; 
Neha;> ,Uky;> the;jp> faNeha;> mUrp> mrPuzk;> Ngjp> tha; ePUwy;> gpuik> 
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#iy> njhg;Gisr; Rw;wp typ> tapWg;gy;> Jhf;fj;jpy; gy;fbj;jy;> khiyf;fz;> 
Foe;ijfspy; tpistpg;gNjhL> rpy rkak; Foe;ijfspy; ,rpT (njw;fj;jpf;fiz) 
cz;lhFk;NghJ ngupa ehfg;G+r;rpfs; Nky; Nehf;fp njhz;ilapy; Vwpr;nrd;W 
the;jp nra;a KbahjthW Rthrf;Foy;> ehrpjj;Jthuq;fs; ,tw;wpy; Eioe;J 
milj;J kuzj;ijAk; cz;lhf;FtJz;L. Foe;ijfs; epj;jpiu nra;Ak;NghJk; 
,t;tpjk; kuzk; rk;gtpf;ff; $Lk;. 
md;wpAk; Flw;fpUkpapdhy; fpuhzp> gTj;jpuk;> %yk;> kyf;fl;L> Njf fhq;if 
Mfpa Neha;fSKz;lhFk;. kw;Wk; rpytiff; fpUkpfshy; Ruk;> kapu; cjpu;jy;> 
Fl;lk;> nrhwp> rpuq;F> gil> fug;ghd; Kjypa rUkNuhfq;fis cz;lhf;fp 
epwkhwr; nra;Ak;> FiwNehiaAk; tpistpf;Fk;. 
 
3.1.3.3ehf;Fg;G+r;rp Nehapd; FwpFzq;fs;: 
ACCORDING TO TEXT BOOK OF BAALA VAAGADAM: 
“Ngr;ir ,dpf;Nfs; ngUtapWq; nfhg;G+Ok; 
fha;r;rYl Ndhf;fhsk; ff;FNk – Nka;r;rYW 
G+r;rpaJ ehfkhk; G+itNa ePawpe;J 
ePr;rwNt itkUe;ij Nju.;” - ghythflk; nra;As; (43) 
 
nghUs;: 
tapW ngUj;jy;> nfhg;G+o; kyu;jy;> fha;r;ry;> Xf;fhspj;J the;jp vLj;jy; 
,f;FwpFzq;fs; ,Ue;jhy; ehf;Fg;G+r;rp ,Uf;Fk; vd;W mwpe;J nfhs;s Ntz;Lk;. 
 
3.1.3.4 ACCORDING TO SIDDHA LITERATURE PILLAI PINI MARUTHUVAM: 
,e;Nehapy; tapw;W cg;Grk;> mbtapW fy;Nghy; jpuz;bUf;Fk;> njhg;Gisr; 
Rw;wp typ> Jhf;fj;jpy; gy; fbj;jy;> ,rpT(typg;G)> Mrdg; gFjpapy; mupg;G> 
the;jp> Ruk;> tapw;Wg;Nghf;F> Ritapd;ik> nrupahik> fopr;ry; Mfpa 
FwpFzq;fs; fhZk;. rpy rkaq;fspy; G+r;rpfs; mjpfkhf ngUfptpl;lhy; 
kyj;NjhlhfpYk;> the;jpNahlhfpYk; ntspNaWk;. ehf;Fg;G+r;rpfs; rpy Ntis 
kyj;Jthuj;ijAk; milj;Jf;nfhs;tJz;L. Foe;ijfs; cz;Zk; Mfhuj;jpy; 
cs;s rj;Jf;fis ,it cwpQ;rp tsu;tjhy; Foe;ijfs; td;ik Fiwe;J 
ntSg;G NehAk;> mij njhlu;e;J Cjy; NehAk; cz;lhFk;. Njhypy; 
ntz;Gs;spfs; Vw;gl;L Njhypd; epwk; khwy;> jbg;G> mupg;G> jpdT> nrhup> rpuq;F 
Kjypad Vw;gLk;. ,itNa my;yhky; ,Uky;> faNeha;> mUrp> tha;eP&uy;> #iy> 
khiyf;fz;> %f;fpy; Gz; cz;lhjy; Nghd;w Neha;fSk; Fly; fpUkpapdhy; 
cz;lhFk;. 
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3.1.3.5.ACCORDING TO SIDDHA LITERATURE DHANVANDHRI VAIDHYAM: 
jd;te;jpup itj;jpa Ehypy; fpUkpfspd; Nju;Tf;Fwpfisg; gw;wpf; $Wk;nghOJ> 
  
  “typj;jpLk; kyk; tplhNj ehNlhWe; jq;fp khq;Nf 
  fypj;jpLQ; rpy GFj;jhd; fhaj;ij kpff; nfLf;F 
  kghd kl;Lk; erer ntd;wwpe;J Nehth 
  kyj;jpdpw; fpUkp Nju;Tkpit nad tFf;fyhNk” 
  
      - jd;te;jpup itj;jpak; (208) 
 
tapw;Ws; thA cz;lhfp jpde;NjhWk; kyk; Nghfhky; Flypy; jq;Fk.; 
rpWrpW GOf;fs; Nru;e;J cliy tUj;Jk;. Mrd thapy; ererntd;W mupg;ig 
je;J typiaAk; nfhLf;Fk.; ,it fpUkp Neha;f;Fwpfs; MFk;. 
 
3.1.3.6.ACCORDING TO SIDDHA LITERATURE PARARASA SEGARAM: 
  “ehf;Fg;G+r;rpapdhLq; FzQ; nrhy;ypw; 
  NghFk; the;jp nghUKk; tapwJ 
  NtF neQ;Rk; tapW fhnyhL if” 
     - guuhrNrfuk; (217) 
ehf;Fg;G+r;rpapdhy; the;jp> tapw;Wg;nghUky;> tapw;Wtyp> neQ;Rtyp> if fhy; 
typ Vw;gLk; vdTk;> ehf;Fg;G+r;rpf;F kUj;JtKk; $wg;gl;Ls;sJ. 
 
3.1.3.7.ACCORDING TO SARABENDHIRA SIDDHA MARUTHUVA SUDAR: 
ruNge;jpu rpj;j kUj;Jtr; Rlupy; tapW ngUj;J njhg;Gs; kyu;r;rpaile;J> 
fha;r;ry;> the;jpNgjp cz;lhFk;. tapw;Wtyp ,Uf;Fk;. ruPuk; ,isj;Jf; 
fhzg;gLk;. Nkw;$wpa FwpFzq;fs; ,Ue;jhy; ehf;Fg;G+r;rp Neha; vd mwpe;Jf; 
nfhs;s Ntz;Lk;. 
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3.1.3.8.jPUk; FwpFzq;fs;: 
  “tapwjdpw; G+ehfe;jd;id rhu;e;J 
  tUj;jpaJ Gw;WNghy gw;wp fhZk; 
  vOk;gpaJ fpUkpjhdpile;J Gf;fpy; 
  ,ay; ngUFq;Foy; kltha; nrhy;yf;NfS 
  fapW KWf;fptpl;lhw; Nghy; Njfe;jd;dpy; 
  fwfwj;J nrhwpahfpf; fhZk; rPo;ePu; 
  capu; ngUFk; gz;bjNu fug;ghd; nra;Ak; 
  cWjp jd;d ed;whf Cuzpg;ghNu” 
       - FUehb 
  “Ngr;ir ,dpNfs; ngUtapWk; nfhg;G+Ok; 
  fha;r;rYk; Ndhf;fhsk; ff;FNk – Nka;r;Ryw 
  G+r;rpaJ ehfkhk; G+itNa ePawpe;J 
  ePr;rwNt itkUe;ij Nju;”  
       - ghythflk; nra;As; (43) 
Symptoms of distended abdomen, fever with nausea and vomiting can be easily 
cured with Naakku puchi noi medicines, if left untreated it may lead to further 
complications like bloated stomach, itching all over the body, piles etc and these are also 
curable. 
 
3.1.3.9.jPuhf; FwpFzq;fs;: 
  “GOthe;jp Fwpfs; Gfof;Nfz;Nkh 
  tsp Kjy; %d;Wk; tifaha;j; jdpj;jdp 
  kpFjypdhYk; tpuTtjhYk; 
  mfl;by; khu;gpy; milj;J kyj;jpy; 
  GOf;fs; kpf;fha;g; GOe;J njspe;J 
  tapW typj;jy; tpf;fYld; eLf;fy; 
  nrapWw khu;gpy; Neha; Jlj;jy; 
  NfhsG kpUjy; nfhz;L the;jp 
  tpoyhFk; mjdpw; GOf;fs; 
  ntspah nkd;W tpsk;gpdhud;Nw” 
       - rpj;j kUj;Jthq;f RUf;fk; 
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In Naakku puchi noi, the worms entering the pharynx and throat block their passage 
and the worms entering the nostrils and lungs interfere the respiratory function and 
ultimately reach an incurable stage which leads to the death of the patient. 
Increase of mukkuttrangal, salivation, vomiting of worms, chest pain, and 
shivering, unbearable stomach pain are the symptoms which indicate that the disease of 
Naakku puchi noi cannot be cured. 
 
3.1.4.PINIYARI MURAIMAI (Neha; fzpg;G) 
Piniyari muraimai is a method of diagnosing a disease. 
 “Pini” means - Disease 
 “Ari” means - Identify 
 “Muraimai” means - Method 
This is based upon three main principles and Envagai Thervugal. The three main 
principles are, 
v Poriyal arithal (Inspection) 
v Pulanal arithal (Palpation) 
v Vinathal (Interrogation) 
Physicians ‘Pori’ and ‘Pulan’ are used as tools for examing the ‘Pori Pulan’ of the 
patient 
 
3.1.4. 1.Poriyal arithal (Inspection) 
Pori is considered as the five sense organs of perception namely, 
v Nose 
v Tongue 
v Eye 
v Skin 
v Ear 
3.1.4.2. Pulanal arithal (Palpation) 
Pulan is functions of five sense organs. They are, 
v Smell 
v Taste 
v Vision 
v Sensation of Touch 
v Hearing 
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3.1.4.3. Vinathal (Interrogation) 
Vinathal is asking the information regarding the history of the disease, its clinical 
feature etc., from the patient or his close relatives who are taking care of him. 
 
3.1.5.msitfs; (Logics) 
Alavaigal are used in clinical diagnosis of a disease. 
  “msit fhz;ly; fUjy; ciu mghtk; nghUs; xg;ghnwd;gH 
  msit NkYk; xopGz;ik iajpfj; Njhbay; ngd ehd; 
  fsit fhz;gH mitapw;wpd; NkYk; miwtH mitnay;yhk; 
  msit fhz;ly; fUjy; ciu vd;Dk; %d;wpylq;fpLNk”. 
 
       - rptrpj;jpahH msit vz;. 6 
The above mentioned “ten alavaigal” comes under three alavaigal mentioned below. 
 
3.1.5.1. Kaandal ( Inspection by Siddha method) 
Through ‘Kaandal’ the physician can directly see the patient, hear all the 
complaints and at length concludes a diagnosis. 
 
 
3.1.5.2. Karuthal (Through Siddha Investigations) 
Through Envagai thervu, Neerkuri and Neikuri, we can diagnose a disease by 
Karuthal. 
 
3.1.5.3. Urai ( Literature evidence of Siddha) 
Through Comparative study of the signs and symptoms of the patient with the 
reference books of Siddha literature, the diagnosis can be concluded. 
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3.1.6.Ennvagai thervugal (Eight diagnostic tools): 
Siddhars have developed a unique method of diagnosing the disease by “En vagai 
thervugal”. 
  “ehbg;ghprk; ehepwk; nkhoptpop 
  kyk; %j;jpukpit kUj;JtuhAjk;.” 
   - rpj;j kUj;Jt Neha;ehly; Neha;Kjy; ehly; jpul;L 
  “nka;f;Fwp epwk;njhdp tpop ehtpUkyk; iff;Fwp” 
        - NjiuaH 
  “ juzpAs;s tpahjp jd;id al;lhq;fj;jhy; 
  jhdwpa Ntz;LtJ NaNjh ntd;dpy; 
  jPuzpaNjhH ehb fz;fs; rj;jj;NjhL 
  Njfj;jpdJ ghprk; tUzk; ehf;F 
  apuzky %j;jpukhkpitf nsl;L 
  apjk;gplNt jhd; ghHj;Jf; FwpAq; fz;L 
  gudUshy; nghpNahHfs; ghjk; Nghw;wpy; 
  gpd;G jtwhky; gz;bjQ; nra;tPNu” 
       - mfj;jpaH Fzthfl ehb 
Hence the diagnosis is made by the following tools: 
1. Naadi (Pulse) 
2. Sparisam ( Sensation to touch) 
3. Naa (Tongue) 
4. Niram (Colour) 
5. Mozhi (Voice) 
6. Vizhi (Eyes) 
7. Malam (Faeces) 
8. Moothiram( Urine) 
 
3.1.6.1.Naadi (Pulse) 
clypy; capH jhpj;jpUg;gjw;Ff; fhuzkhd rf;jp vJNth mJNt jhJ 
my;yJ ehb vdg;gLk;. 
  “ehb vd;why; ehbay;y euk;gpy; jhNd 
  eykhfj; Jbf;fpd;w JbjhDky;y 
  ehb vd;why; thjgpj;j rpNyw;gdKky;y 
  ehb vOgj;jPuhapue; jhDky;y 
  ehb vd;why; mz;l Nguz;lnky;yhk; 
  ehb vOtifj; Njhw;wj;Js;sha; epd;w 
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  ehbaJah uha;e;J ghHj;jhuhdhy; 
  ehbAWk; nghUs; njhpe;J ehLthNu” 
       - gjpnzz; rpj;jH rjfehb E}y; 
Naadi is a special diagnostic tool used by Siddhars. It can be felt one inch proximal 
to the wrist on the radial side by means of palpation with the tip of index, middle and ring 
fingers corresponding to Vatham, Pitham and Kabam respectively. 
  “toq;fpa thjk;khj;jpiu nahd;whfpy; 
  joq;fpa gpj;je;jd;dpyiu thrp 
  moq;Fq;f ge;jhilq;fpNa fhNyhby; 
  gpoq;fpa rPtu;f;Fg;gpr nfhd;Wkpy;iyNa” 
        - Fzthflk; 
The three humours Vatham, Pitham and Kabam exits in the ratio 1:1\2:1\4 
physiologically. Dearrangement in these ratios leads to various disease entities. The three 
“Uyir thathukal” are formed by the combination of three naadigal with three vayu 
a) Edakalai + Abanan = Vatham 
b) Pinkalai + Piranan = Pitham 
c) Suzhumunai + samanan = Kabam 
 
,Ue;jNghjpYk; Foe;ijfSf;F ehb fzpg;gJ fbdk; vd;gij fPo;fz;l rjfehb 
ghly; Fwpg;gpLtJ 
  “nfhz;blNt faNuhfp fhr Nuhfp 
  Fwpg;ghfr; rpw;wpd;gk; nra;j NgHfs; 
  mz;blNt jhpj;jpuHfs; tpUj;jH ghyH 
  md;ghfj; jz;zPhpy; %o;fpNdhHfs; 
  nfhz;blNt ,tHfsJ cWg;gpd; jhJ 
  $wNt KbahJ vtHf;Ff; fpl;Lk; 
  gz;blNt apg;ghPl;ir ahHjhd; fhz;ghH 
  guhguj;jpd; kfpikapJ ghU ghNu” 
        - rjf ehb 
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As per siddha literature SadhagaNaadi, Naadi in Kudal Kirumi is given as Vatha Naadi. 
  “thjnkDk; ehbaJ Njhd;wpy; 
  rPjke;jnkhL tapW nghUky; jpul;rp tha;T 
  rPjKWq;fpuhzp kNfhjuk; ePuhik 
  jpus;tha;T #iy typfLg;Gj; jPiu 
  ePjKWq ;fp UkpFd;kk; mz;l thjk; 
  epiyAk; ePu;f; fpupr;ruq;fs; je;J Nkfk; 
  Ngjfkh Kjugpzp %yNuhfk; 
  Ngr ntF gpzpfSNk nghUsjhNk” - rjf ehb 
nghUs;: 
thjehb kPwp elf;fpy; rPjk; tpoy;, tapWggy;, zthAj;jpul;rp, fpuhzp, 
kNfhjuk;, ePuhik tha;T, #iy typ, fLg;G, fpUk, Fd;kk mz;lthjk,; 
ePh;f;fphpr;ruk; je;J Nkfk; tapw;W Neha; %yNuhfk; Mfpa FwpFzq;fis 
tpistpf;Fk;. 
 
3.1.6.2. Sparisam 
Sparisam is a method of palpation and percussion to know the condition of the body 
like warmth, fever, chillness, sweating, numbness, parasthesia, dryness of the body, 
erosion, patches, ulcers, oedema, emaciation, swelling, obesity and enlargement of liver, 
spleen. 
 
3.1.6.3. Naa 
This is the method of inspection of the tongue mainly gums, teeth, lips, palate etc. to 
find out the colour changes according to vatha, pitha, kaba and mukkutra disease, by 
noting the tongue’s dryness or wetness, excessive salivation, redness, ulceration, pallor, 
any malignant growth, predominant taste in the tongue, speech and movement of tongue. 
 
3.1.6.4. Niram 
Colour indicating the vatha, pitha, kaba, mukkutram, yellow, pallor, redness of the 
skin, bluish discoloration of conjunctiva and nail beds are noted. 
 
3.1.6.5. Mozhi 
Clarity of voice, any disturbances, sound voice, slurring, crying, talk induced by 
hallucination are noted. 
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3.1.6.6. Vizhi 
Abnormal colour changes indicating the mukkuttram. Pallor, excessive lacrimation, 
accumulation of secretion at the angle of eyes, subconjunctival bleeding, and any specific 
disease of the eyes are noted. 
 
3.1.6.7. Malam 
Quantity, colour, odour, froth, abnormal consistency, indigestion, frequency, 
constipation are noted. 
  “fUj;jkyk; ge;jkyq; fhyhFk; gpj;jQ; 
  rpWj;jK\; zQ;nrk;ik NrUk; - tUj;jKiw 
  rPjkyk;ntz;ikahk; Nru;e;jgy Nuhfpap 
  Vjky nke;epwK Nk.” 
  “kykJ fl;b Kl;bahapLk; thjj;jpw;F 
  kykJ jk;gyk;Nghy; kQ;rshk; gpj;jj;jpw;F 
  tykwr; rpf;fyhf ntSj;jpL ikaj;jpw;F 
  kykjpd; yl;rzj;ij tFj;jdu; Kdptu; jhNk.” 
         - Gypg;ghzp 
 
3.1.6.8. Moothiram 
Quantity, colour, odour, froth, frequency, retention, deposits, presence of abnormal 
constituents such as sugar, protein etc are noted. 
Determination of Neerkuri and Neikuri is a special diagnostic method mentioned in 
Siddha literatures and it may be the first laboratory investigation in the history of 
medicine. 
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3.1.7.Neerkuri and Neikuri: 
epwf;Fwp nea;f;Fwp epr;rpaj;jw;Fhpa ePh; ,yf;fzk;: 
  “mUe;J khwpujKk; mtpNuhjkjha; 
  m/fy; myHjy; mfhyT+z; jtpHe;jow; 
  Fw;ws tUe;jp cwq;fp itfiw 
  Mbfyrj; jhtpNa fhJ nga; 
  njhU K$u;j;jf; fiyFl; gLePhpd; 
  epwf;Fwp nea;f;Fwp epUkpj;jy; flNd.” 
      - Neha; ehly; Neha; Kjy; ehly; jpul;L 
Prior to the day of urine examination the patient is instructed to take a balanced diet 
and quantities of food must be proportionate to his routine intake. The patient should have 
good sleep. After waking up in the morning, the first urine voided is collected in a clear, 
wide mouthed glass container and is subjected to analysis of “Neerkuri and Neikuri” 
within one and half an hour. 
 
 
Neerkuri 
  “te;j ePHf;fhpvil kzk; Eiu vQ;rnyd; 
  iwe;jpaYsit aiwFJ KiwNa” 
       - rpj;j kUj;Jthq;f RUf;fk; 
vd;gjhy; ,opfpd;w ePUf;F 1)epwk; 2)vil 3)ehw;wk; 4)Eiu 5)Fiwjy; vd 
[e;J ,ay;fs; cz;L. 
 
Voided urine has the following characters 
1. Niram - Colour 
2. Edai - Specific gravity 
3. Manam - Smell 
4. Nurai - Frothy Nature 
5. Enjal - Quantity of urine voided 
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Neikuri 
The speciality of neikuri is stated in the following verses, 
  “If;Fwp nfhLtl thdpo ykHe;NjhH 
  iff;Fwp njhpj;j eq;flTisj; Jjpj;Nj 
  nka;f;Fwp epwe;njhdp tpop ehtpU kyk; 
  iff;Fwp KotJ} cq;fw;whH jk;kpDk; 
  ngha;f;Fwp nka;f;Fwp GfYnk tHf;Fk; 
  nea;f;Fwp ajid ape;ePzpyj; Jiug;Nghk;” 
   - rpj;j kUj;Jt Neha; ehly; Neha; Kjy;ehly; jpul;L 
The Neikuri process with gingely oil, 
  “epwf;Fwpf; Fiuj;j epUkh zePhpw; 
  rpwf;f ntz;nza; NahH rpWJsp eLtpLj; 
  njd;Wwj; jpwe;njhyp Nafhjikj;jjp 
  dpd;wjptiy Nghk; newp tpopawpTk; 
  nrd;wJ GfYQ; nra;jpia AzNu” 
   - rpj;j kUj;Jt Neha; ehly; Neha; Kjy;ehly; jpul;L 
The collected specimen as said above is to be analysed by following method. The 
specimen is kept open in a glass container. It is to be examined under direct sunlight, 
without shaking the vessel. Then add a drop of gingely oil at a distance of 1/2 or ¾ inch 
height, observe keenly the direction in which it spreads within few seconds, and conclude 
the diagnosis as follows, 
  “muntd ePz;bd/Nj thjk;” 
vz;nza;j;Js ghk;igg; Nghy; ePz;lhy; mJ tspNehiaf; Fwpf;Fk; 
  “Mop Nghw;gutpd; m/Nj gpj;jk;” 
Nkhjpuk; Nghy; ,iltpl;L gutpdhy; mJ gpj;j Nehiaf; Fwpf;Fk; 
  “Kj;njhj;J epw;fpd; nkhoptnjd;fgNk” 
vz;nza;j;Jsp tpl;lJ tpl;lthNw rpwpJk; guthky; Kj;Jg;Nghy; epw;Fkhdhy; mJ 
IaNehiaf; fhl;LtjhFk;. 
   - rpj;j kUj;Jt Neha;ehly; Neha; Kjy; ehly; jpul;L 
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3.1.8.Paruvakaalam (Seasonal Variations): 
As the earth revolves around the sun it gets sunlight at various positions. With 
reference to the position of the earth towards the sun, year is divided into six seasons. 
 
They are, 
S.No Kaalam Kuttram State of Kuttram Suvai 
1. Kaar Kaalam 
(Aavani-Puratasi) 
(Aug16 – Oct 15) 
Vatham -- 
Pitham --- 
Vettrunilai Valarchi 
Thannilai Valarchi 
Enippu 
Pulippu 
Uppu. 
2. Koothir Kaalam 
Iypasi – Karthigai 
(Oct16 – Dec15) 
Vatham --- 
Pitham ---- 
 
Thannilai Adaithal 
Vettrunilai Valarchi 
 
Enippu 
Kaippu  
Thuvarppu 
3. Munpani Kaalam 
( Markazhi – Thai) 
(Dec16 – Feb15) 
Pitham ---- Thannilai Adaithal 
 
Enippu 
Pulippu 
Uppu 
4. Pinpani Kaalam 
(Masi – Panguni) 
(Feb16 – Apr15) 
Kabam ---- 
 
Thannilai Valarchi Enippu 
Pulippu 
Thuvarppu 
5. Elavenil Kaalam 
(Chithirai – Vaikasi) 
(Apr16 – Jun15) 
Kabam ---- Vettrunilai Valarchi 
 
Kaippu 
Karppu 
Thuvarppu 
6. Mudhuvenil Kaalam 
(Aaani – Aadi) 
(Jun16 – Aug15) 
Vatham --- 
Kabam ---- 
Thannilai Valarchi 
Thannilai Adaithal 
 
 
Enippu 
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3.1.9.Five types of lands : They are, 
1. Kurinji : Mountain regions and surroundings 
2. Mullai : Forest regions and surroundings 
3. Marutham : Cultivating regions and surroundings 
4. Neithal : Sea and Coastal regions 
5. Palai : Desert land only 
 
3.1.10.Udal kattugal: They are, 
1. Saaram : It gives strength to the body and mind 
2. Senneer : Saaram after absorption is converted into senneer. It is 
    responsible for knowledge, strength, boldness, and healthy complexion 
3. Oon : Gives structure and shape to the body and is responsible 
    for the movement of the body. 
4. Kozhuppu : Lubricates the organs to proceed on its own work 
5. Enbu : Protects the vital organs and used for movements and 
    nominates body structure. 
6. Moolai : Present inside the bones and it gives strength and 
    maintains normal condition of the bone. 
7. Sukkilam (or) 
    Suronitham : Responsible for the reproductive functions of species. 
 
3.1.11.Mukkutram: 
  “cw;wNjhu; clypd; $W 
  cWg;Gld; tPuyp epw;W 
  Kw;WNk Neha;fs; vy;yhk; 
  Kjy;jdpy; Njhd;Wk; NghJ 
  gw;WNk thj gpj;j 
  rpNyw;gde; jd;dpy; xd;iwAk; 
  gw;wpNa Njhd;Wk; vd;W 
  gfu;e;jdu; Kdptu; jhNk” 
        - mfj;jpau; FUehb 
Human body is influenced by mukkutram (ie) Vatham, Pitham and Kabam. They 
are responsible for normal physiological conditions of the body. 
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3.1.11.1.Vatham 
Vatham is a kinetic energy, which influences all movements. 
Vatham is located in the abanan, idakalai, faeces, spermatic cord, iliac bone, skin, 
nerves, joints, hair follicles, muscles, bone, ear and thigh. 
Vadham represents vayu, mind, dryness, pain, flatulence, sensitiveness, lightness 
and also air. 
Vadham is classified into 10 types. They are 
Name Locations Physiologic Functions 
 Name Locations Physiologic Functions 
1. Pranan 
 
Heart, Lower 
and Upper 
Respiratory 
Tracts 
Controls knowledge, mind and five objects 
of sense, useful for breathing 
2. Abanan Lower abdomen 
and extremities 
Responsible for urination, expels faeces and 
foetus, discharge sperm and menstruation. 
3. Viyanan Mainly at heart Responsible for movement of all parts of the 
body and used to feel the sensation 
4. Uthanan Chest Responsible for vomiting, cough, hiccough, 
sneezing 
5. Samanan Stomach Aids for proper digestion.  It controls the 
activity of other vayus 
6. Naagan Eyes Responsible for opening and closing of the 
eyes 
7. Koorman Heart and Eyes Responsible for vision and yawning and 
controls lacrimation 
8. Kirukaran Throat Responsible for salivation, nasal secretion 
and appetite 
9. Dhevathathan Eruvai & 
Karuvai 
For laziness, sleeping and anger 
10. Dhananjeyan Nose Responsible for bloating of the body after 
death.  It escapes on the third day after death 
through the cranium when it bursts. 
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3.1.11.2.Pitham: 
Pitham is responsible for all the transformation. Pitham is located in urinary 
bladder, heart, head, umbilicus, abdomen, blood, sweat, skin and eyes. 
Pitham is classified into 5 types.  
They are, 
1. Analapitham - Responsible for digestion of food 
2. Ranjagapitham - Responsible for colour of blood 
3. Saathagam - Located in heart and is responsible for normal 
    activities of the body 
4. Alosagam - Responsbile for normal vision 
5. Prasagam - Responsible for the complexion of skin 
 
3.1.11.3.Kabam: 
Stabilizes, maintains and lubricates all movements. Kabam is found in samanan, 
semen, brain, head, tongue, nose, bones, bone marrow, fat, nerves, chest, blood, large 
intestine, eye, stomach and pancreas. 
Kabam is classified into 5 types, they are. 
1. Avalambagam : Heart is the center for Avalambagam. It controls all other forms of      
    kabam. 
2. Klethagam : Stomach is the center for klethagam. It gives moisture and softness to   
    the  ingested food and helps for digestion 
3. Pothagam : Tongue is the center for pothagam and it is responsible for the sense of  
    taste. 
4. Tharpagam : Head is the center for tharpagam. It gives cooling effect to eyes. 
5. Santhigam : It lies in the joints and is responsible for the locomotion. 
 
3.1.12.Abnormal Functions  of  Mukkutram. 
Abnormal functions of Vatham: 
Pain in the wholebody, twitching, piercing pain, inflammation, red coloured 
complexion and also roughness of the skin.Hardness of the limbs, astringent taste, 
sweating, and numbness or paralysis of the limb, tremors, muscular wasting, severe pain, 
decrease in the amount of excretion of stools and urine, thirst, blackish discolouration of the 
skin, stools, urine. 
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Abnormal functions of Pitham 
Indigestion, hyper acidity burning sensation over the stomach, chest and throat. 
 
Abnormal functions of Kabam 
Pale skin complexion, cold, itching, dullness, heaviness, oilyness, loss of 
sensation, a sense of sweetness in mouth. 
 
 
 
  
Humor Increased Condition Decreased Condition 
Vatham Distended abdomen,  
Constipation, 
Weakness,Insomnia,Tremors, 
Breathlessness, 
Blackish discolouration 
Body pain, Feeble 
Voice,Syncope, 
Diminished  
capability of brain 
Pitham Yellowish discolouration of eyes, 
skin, urine and motion. 
Polyphagia, Polydypsia, 
Burning sensation all over the body, 
Sleeplessness 
Cold,Pallor,Decreased 
appetite 
 
Kabam Loss of appetite, 
Excessive salivation, 
Heaviness, 
Dyspnoea, 
Excessive sleeping, 
Whiteness, 
Diminished activity. 
Prominence of bone 
edges,Dry cough, 
Lightness,Profuse 
sweating, Palpitation 
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3.1.13.Udal Vanmai – Body Immunity 
Udal Vanmai – Body Immunity: 
The Udal Vanmai is classified into 3 types. They are, 
1. Iyarkai Vanmai 
2. Seyarkai Vanmai 
3. Kaala Vanmai 
1. Iyarkai Vanmai 
Natural immunity of the body itself by birth 
2. Seyarkai Vanmai 
Improving the health by intake of nutritious food materials, activities and 
medicines. 
 
3. Kaala Vanmai 
Development of immunity according to age and the environment. When Udal 
Vanmai is affected there may be a possibility of infestation with Kudal Kirumi. 
 
3.1.14.Gnanenthiriyam: They are, 
1. Mei : Feels all types of sensation. 
2. Vai : For recognizing taste 
3. Kann : Meant for vision 
4. Mooku : For recognizing smell 
5. Sevi : For hearing 
 
3.1.15.Kanmenthriyam: They are, 
1. Kai : Majority of normal works done by hands 
2. Kaal : For walking 
3. Vaai : For Speaking 
4. Eruvaai : For defaecation 
5. Karuvaai : For reproduction. 
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3.1.16.MARUTHUVAM 
Line of Treatment: 
Siddha treatment is not only for complete healing but also for prevention and 
rejuvenation. 
  “Neha;ehb Neha;Kjy; ehbmJ jzpf;Fk; 
  tha;ehb tha;g;gr; nray;” 
         - jpUf;Fws; 
  “cw;whd sTk; gpzpasTq; fhyKq; 
  fw;whd; fUjpr; nray;.” 
         - jpUf;Fws; 
So, it is essential to know the disease, the aetiology, nature of the patient, severity 
of the illness, the seasons and the time of occurrence clearly. 
 
In siddha medicine, the line of treatment is based on the principles mentioned 
below, 
1) Kaappu (prevention) 
2) Neekkam (Treatment) 
3) Niraivu (Restoration) 
 
1. Kaappu (Prevention) 
As per Siddha system, even during the time of conception, the vinaipayan is 
transferred into the fertilized embryo, which is the aetiology for certain diseases and may 
be cured not only by medicines but also by teaching the following habits 
The patients should be advised on personal hygienic principles and also instructed 
to avoid drinking polluted water, taking improperly cooked vegetables and unhygienic 
foods. 
The children should be encouraged to wear shoes while playing in the field which 
are likely to be contaminated with infected faeces. 
Advised to follow proper and hygienic toilet measures i.e., to wash their hands 
after defaecation and before taking food. 
Cleanliness of the nails should be emphasised by cutting and trimming the nails 
regularly and also to stop the habit of biting the nails. 
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2. Neekam (Treatment) 
 The aim of treatment is based on, 
a. To bring the three doshas into normal equilibrium state, emetics and purgatives 
are given. But the children are already weak. So, the administration of purgatives 
and emetics are excluded from line of treatment. 
b. To treat the patient according to the symptoms by internal medicine Kudal kirumi 
choornam. 
 
3.1.17.Pathiyam: 
 During the course of treatment, the drug is administered to the patients according to 
the nature of disease and quoted as follows 
  “gj;jpaj;jpdhNy gyDz;lhFk; kUe;J 
  gj;jpaq;fs; Nghdhy; gyd; NghFk; - gj;jpaj;jpy; 
  gj;jpaNk ntw;wpjUk; gz;bjHf;F Mjypdhy; 
  gj;jpaNk cj;jpnad;W ghH”  
        -NjiuaH ntz;gh 
The patients with Kudal Kirumi were advised to avoid unhygienic foods. 
 
3. Niraivu (Restoration) 
1. Reassurance of disease recovery was given to all patients 
2. All the patients were advised to lead a healthy life without any exposure to 
disease. 
 
3.1.18.Diet: 
  “kUe;Nj czT czNt kUe;J” 
         - jpU%yH 
  “khWghb y;yhj cz;b kWj;Jz;zpd; 
  CWgh by;iy capHf;F” 
- jpUf;Fws; 
vd;gjpdhy;> cz;Zk; czTg; nghUspYk; ftdk; nrYj;j Ntz;Lk;. 
 Good diet is the most important factor to maintain one’s health. Good diet is one, 
which should not affect the health by increasing or decreasing the mukkutram. 
In case of children affected by Naakku puchi noi, the diet should be in easily 
digestable form and should be a nutritional one. 
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In Naakku puchi noi, Saaram and Senneer which are easily affected can be 
corrected by taking Boiled rice, Milk rice, Ghee rice, Green leafy vegetables, vegetables 
and fruits. 
 
 Rice flakes and Rice flakes balls can be taken to avoid Nausea and various digestive 
problems (as quoted in Agasthiyar Gunavagadam text). 
 
Keerai vagaikal (greens) 
Greens like karisalai, ponnanganni, arukerrai, sirukeerai, murungai keerai having 
haematinic property may be given daily.In worm infestation agathi keerai, paagarkai, 
pudhina, paruppu keerai has to be given (as quoted in Agasthiyar Gunavagadam text). 
Kaikarigal (vegetables) 
 
 Kathiri pinju, avarai pinju, murungai pinju, vazhai kachal may be given along with 
other food stuffs. 
 
Pazhavakaigal (fruits) 
 
 Paereechai, naaval, maadhulai, aththi are rich source for iron which are to be taken  
regularly. 
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REVIEW OF LITERATURE 
3.2MODERN ASPECT 
ASCARIASIS 
ASCARIASIS  
 Today, ascariasis is among the most important tropical diseases in humans with more 
than billion infected people world-wide.  
 
3.2.1.Definition: 
 It is an infection of the intestinal tract caused by the adult Ascaris lumbricoidesand 
clinically manifested by vague symptoms of abdominal pain, nausea and cough. Live worms 
are passed in stools or through vomiting. 
 
3.2.2.Incidence: 
 Ascariasis is perhaps the most common human helminthic infection with over 1 
billion infected persons in the world. In India, the incidence may be as high as            80-100 
% in rural areas with poor sanitation. 
 
3.2.3.Epidemiology:  
 Ascariasis is mostly seen in tropical and subtropical countries because of warm and 
humid conditions that facilitate development and survival of eggs. The majority of infections 
occur in Asia (up to 73%), followed by Africa (~12%) and Latin America (~8%). 
 
3.2.4.Historical Information:  
 Ascariasis is an ancient infection, and A. lumbricoides have been found in human 
remains from Peru dating as early as 2277 BC. There are records of A. lumbricoides in 
Egyptian mummy dating from 1938 to 1600 BC. Despite of long history of awareness and 
scientific observations, the parasite's life cycle in humans, including the migration of the 
larval stages around the body, was discovered only in 1922 by a Japanese pediatrician, 
Shimesu Koino 
 
  
  
31 
 
3.2.5.Causative Agent: 
The causative agent is the largest intestinal nematode Ascaris lumbricoides, commonly 
known as Roundworm. It was discovered by Linnaeus in 1758. Its life cycle was worked out 
as late as in 1916. 
 
3.2.6.Scientific classification: 
Kingdom : Animalia 
Phylum : Nematoda. 
Class : Secernentea 
Order : Ascaridida 
Family : Ascardidae 
Genus : Ascaris 
Species : Ascaris lumbricoides. 
Binomial name : Ascaris lumbricoides (Linnaeus ,1758) 
3.2.7.Route of Transmission: 
 Transmission is primarily hand to mouth but may also involve ingestion of 
contaminated raw fruits and vegetables. Infection occur particularly by  consumers of 
uncooked vegetables and fruits grown in or near soil fertilized with seewage. Infected food 
handlers may contaminate a wide variety of foods.Transmission is enhanced by the high 
output of eggs by fecund female worms and resistance of ova to the outside 
environment.Ascaris eggs can remain viable at 5-10C for long as 2 years.   
 
3.2.8.Habitat: 
 The adult worms are found in the intestine of man, mainly in the jejunum and in upper 
part of the ileum. Similar species are found in Gorillas, Apes and Pigs, but they are not 
identical. 
 
3.2.9.Morphology: 
  These are large, stout nematodes resembling an ordinary earth worm. Freshly passed 
in the stool, the adult worm is light cream or pink in colour. But gradually fades on standing. 
It is cylindrical in shape, tapering at both ends and the anterior end being thinner than the 
posterior end. 
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The mouth opens at the anterior end and possesses three finely toothed lips, one dorsal 
and two ventral. Each lip possesses a pair of sensory papillae on its lateral margin. The body 
is filled with an irritating fluid called “Ascaron or Ascarase” in which digestive and 
reproductive organs float. This fluid when leaked out can cause allergic manifestations. 
 
Male Worm 
It measures about 15 to 25 cm in length with a maximum diameter of 3 to 4mm. The 
tail end of the male is curved ventrally in the form of a hook having a conical tip. The genital 
pore opens into the cloaca from which two curved copulatory spicules protrude. The anus 
opens with the ejaculatory duct into the cloaca. 
 
Female Worm 
It is longer and stouter than the male and measures 25 to 40 cm in length with a 
maximum diameter of 5mm. The posterior extremity is neither curved nor pointed but is 
conical and straight. The anus is subterminal and opens directly on the ventral aspect in the 
form of a transverse slit. The vulva opens at the junction of the anterior and the middle thirds 
of the body on the midventral aspect. This section of the worm is narrower and is called the 
vulvar waist. 
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ASCARIS LUMBRICOIDES 
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Eggs 
 
A gravid round worm may contain as many as 27 million ova and the average output of 
eggs by one worm may be up to 2, 00,000. There are 4 types of Ascaris eggs, 
1. Fertilized eggs with double shell (commonest). 
2. Unfertilized eggs with double shell (10-15% of the total). 
3. Semi – decorticated fertilized eggs (less frequent). 
4. Semi – decorticated unfertilized eggs (very rare). 
I. Fertilized Eggs 
These are round and oval in shape. Outer portion is bile stained or golden brown in 
colour, surrounded by a thick smooth translucent shell with an outer albuminous coat. The 
internal shell is smooth, thick and colourless, containing very large conspicuous unsegmented 
ovum with clear space at each pole. The egg floats in a saturated solution of common salt. 
 
II. Unfertilized Eggs 
These are elliptical in shape. These are bile stained, have a thinner shell with an irregular 
coating of albumin. Inner part contains a small atrophied ovum. These eggs do not float in 
saturated salt solution. 
 
III Semi-Decorticated Fertilized Eggs 
 These have similar features as for fertilized eggs except that the shell is single 
smooth, thick and colourless or very pale yellow. These contain a round colourless 
granular central mass. They freely float in saturated salt solution. 
IV Semi-Decorticated Unfertilized Eggs 
 Shells of these eggs are simple, smooth, thin end colourless. They contain large 
roundish, colourless refractile granules. They do not float in saturated salt solution. 
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Resistance of eggs: 
 Round worm eggs are adversely affected by excessive heat and drying as caused by 
direct exposure to sun. However, they are remarkably resistant to most other environmental 
conditions. Laboratory studies have revealed that the eggs can survive and continue 
maturation even when immersed in 2% formalin, potassium dichromate and 50% solutions of 
Acidic, Nitric, Hydrochloric and Sulphuric acids. This factor adds to the longevity of the eggs 
in the environment. 
3.2.10.Incubation period: 
 The incubation period from infection of the swallowed eggs to the first appearance of 
the eggs in stool is 60-70 days. In larval Ascariasis, pulmonary symptoms occur within 4-16 
days. 
3.2.11.Life span: 
 The worm has a life span of 10-12 months; the eggs have longevity of 3-7 years. 
3.2.12.Life cycle: 
  
 
Developmental stages (life cycle)  
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Life Cycle Stages  
 Roundworms are dioecious, with male and female organs in separate individuals, and 
have a direct life cycle (no intermediate hosts). They mate in host's small intestine and the 
females produce eggs.  
· Egg Single female roundworm can lay up to 240,000 eggs per day. Eggs are passed to 
the environment with feces.  
o Non-infective egg: Non-infective, non-embryonated eggs, are released into 
environment in the feces.  
o Infective egg: In about 20 days, after embryo development, the eggs becomes 
infective; under adequate conditions, these eggs maintain their viability for up 
to 1 year; they are resistant to many noxious chemicals including acids and a 
number of commercial detergents; eggs are disseminated by rain, wind, with 
insects (flies), birds, and other animals; infection in human occurs by ingestion 
of eggs through contaminated food or water, or lack of personal hygiene.  
· Larva Worms hatch in intestine and undergo several moltings before developing into 
egg-laying adults.  
o Larvae in small intestine: Eggs hatch upon reaching the host's small intestine 
and penetrate the intestinal wall.  
o Larvae in liver: Larvae migrate to the hepatic portal circulation invading liver 
in ~1-2 days after infection.  
o Larvae in lungs: L3 larvae migrate up the trachea and are swallowed after 
induced coughing.  
o Larvae in small intestine: L3 larvae reach the intestinal lumen after 8-9 days 
after infection where they molt twice and mature at 2-3 months after infection.  
· Mature adult: After 2 moltings the parasites mature into adults and mate; life span of 
actively feeding and egg-laying adult females is up to 2 years; dead or paralyzed 
worms are expelled from the anus.  
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3.2.13.Immunology:  
 A partial immunity may be acquired by man, induced by the migrating larvae. 
Antigens are liberated during the moulting periods of the larvae and produce protective 
antibodies which lower the worms’ burden. A severe allergic reaction occurs when the larvae 
reach the small intestine for the second time. Eosinophil count is increased at the time of 
tissue invasion. 
3.2.14.Pathology: 
The important pathological features are, 
1. In an uncomplicated intestinal Ascariasis no pathological changes are found. 
2. Infarct or gangrene may develop due to intestinal obstruction, volvulus or local   
    circulatory disturbances. 
3. At sites of ectopic Ascariasis, there is acute or chronic inflammation with                   
infiltration of eosinophils, histocytes and mononuclear cells. 
4. Around the ova in tissues, granuloma formation may occur. 
5. Adult worms in tissue section can be identified based on their typical polymyarian 
    musculature. 
6. Larvae in tissue sections can be identified by their bilateral alae, intestine and two 
    excretory columns 
3.2.15.Clinical features: 
Majority of the infections are symptomless (about 85%2). The severity of the symptoms 
depends both on the number of eggs ingested and on the previous infection history.Symptoms 
can be produced by 
1. Migrating larvae 
2. Adult worm 
3. Toxins released from the worms. 
1) Symptoms produced by migrating larvae: 
 Pathogenic effect of larval migration is due to allergic reactions and not the presence 
of larvae as such. Therefore the initial exposure to larvae is usually asymptomatic except 
when the larval load is very high. But when reinfection occurs, subsequently there may be 
intense cellular reaction to the migrating larvae in the lungs.This may cause symptoms like 
pneumonia. 
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Loeffler’s Syndrome: 
In heavy infection typical symptoms are 
v Fever 
v Cough 
v Dyspnoea 
v Cyanosis 
v Urticaria 
v Pain over the chest 
v Mucoid and bloody sputum 
The sputum may contain charcot-leyden crystals. The larvae may occasionally be 
found in sputum, but are seen more often in gastric washings. The clinical features 
generally clear in one or two weeks. Though it may sometimes be severe, it is rarely fatal. 
Loeffler’s syndrome can also be caused by hypersensitivity to other agents, both living 
and non living. 
Sometimes migrating larvae pass beyond the pulmonary capillaries and reach the 
general circulation and they may reach other organs of the body such as liver, spinal cord 
and kidneys. Very rarely the larvae may occlude a small vessel in the heart and brain. 
2) Symptoms due to adult worms: 
 Clinical manifestations due to adult worms vary from asymptomatic infection to 
severe and even fatal consequences. It is not unusual to find children apparentlyunaffected 
inspite of heavy infestation with the worms. The pathological effects present are caused by, 
1. Spoliative action 
2. Toxic action 
3. Mechanical effects 
1. Spoliative action 
 It is otherwise called as nutritional effects, are usually seen when the worm burden is 
heavy. The worms may be present in enormous numbers, sometimes exceeding 500, 
occupying a large part of the intestinal tract. This interferes with proper digestion and 
absorption of food. Ascariasis may contribute to protein energy malnutrition and vitamin A 
deficiency. 
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2. Toxic action 
 These are due to the hypersensitivity to the worm antigens and may manifested as 
 v Fever 
 v Urticaria 
 v Angioneurotic oedema 
 v Conjunctivitis 
 v Wheezing 
These are more often seen in persons who come into contact with the worm occupationally, 
as in laboratory technicians. 
3. Mechanical effects 
 These are the most important manifestations of Ascaris lumbricoides. Due to 
mechanical irritation there may be abdominal pain, nausea, vomiting, loose motion, 
abdominal distension etc. The worms may be clumped together into a mass, filling the lumen 
of intestine leading to Intussusception, i.e intestinal obstruction. The male worm is more 
responsive to illness of the host, than the female. Typhoid ulcer may be penetrated giving rise 
to perforation of gut; sometimes the worms may be coughed up, vomitted or passed through 
the nose. It may enter the opening of the biliary or pancreatic duct causing acute biliary 
obstruction or pancreatitis. 
 It may enter the liver parenchyma where it may lead to abscesses. It may crawl into 
the trachea and the lung causing respiratory obstruction or lung abscesses. 
Symptoms due to sensitation:  
 The metabolites of Ascaris, both during the period of biological incubation and after 
the worm maturation in small bowels may produce sensitation phenomenon of allergic 
manifestation.  
Such as, 
Skin - Urticaria 
Nose - Rhinitis 
Lungs - Bronchial asthma 
Intestinal Tract - Diarrhoea 
Eye - Conjunctivitis and photophobia 
Excretory system – Haematuria 
The irritation caused by Ascaris lumbricoides is due to the liberation of “Ascarin” by the 
adult worm. 
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3.2.16.Complications: 
1. Peritonitis may be produced by ova of Ascaris lumbricoides. 
2. Ascaris lumbricoides may infest in the caecum and the appendix. 
3. Ascaris lumbricoides in the lumen of the small intestine may cause obstruction. 
4. Ascaris lumbricoides in the biliary passage and liver may cause hepato biliary 
disturbances. 
3.2.17.Diagnosis: 
In this condition, diagnosis can be done by two ways or methods. There are, 
1. Direct evidence 
2. Indirect evidence 
 
1. Direct evidence: 
Demonstration of Adult Worm 
This may be possible in the following situations 
v When worms passed in the faeces particularly after the treatment when the 
parasite gets paralyzed and get propelled by peristalisis. 
v When the worm is vomited out. 
v On radiological examination this may be particularly obvious when two worms 
            are lying parallel like “Trolley car lines”. 
Demonstration of Eggs 
 
 Each female worm produces and lays massive number of eggs per day. One or 
two direct wet mounts are usually sufficient to diagnose an infection with even a small 
number of worms. There are three techniques to demonstrate the eggs. 
1. Concentration technique 
2. Sedimentation technique 
3. Floatation technique(By using Zinc sulphate reagent) 
All types of eggs as described above can be seen in the stool sample. The eggs can also be 
demonstrated on duodenal aspiration of the bile. 
Sputum Examination 
In pulmonary involvement sputum may reveal eosinosphils, charcoat leyden crystals and 
occasionally the larvae of the parasite. 
2. Indirect evidence: 
1. Eosinophilia seen on blood examination in initial stages. 
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2. Dermal allergic reaction positivity using powdered Ascaris antigen. 
3. Sero diagnosis: 
 Serological tests like ELISA, IHA and microprecipitation on larvae are currently 
available for serodiagnosis, which are of particular utility in diagnosis of allergic 
pneumonitis. Their utility is less because of many cross reactions. These tests are useful for 
sero surveys. 
 
3.2.18.Prevention: 
 Ascariasis can be eliminated only if faecal contamination of soil can be prevented. 
The Ascaris egg is highly resistant. Therefore the use of night soil as manure will lead to 
spread of the infection unless destruction of eggs is ensured by proper compositing. 
Treatment of vegetables and other garden crops with water containing iodine 200 ppm for 15 
minutes kills the eggs and larvae of Ascaris and other helminths. 
a) Food 
 Ground (or) fresh vegetables used for making salads should be thoroughly cleaned 
and preferably pealed before use. Pork, beef and fish should be cooked well to destroy the 
infective forms of the parasite embedded in the flesh. 
b) Water 
 The drinking water should be boiled and filtered to prevent infection through 
ingestion of infected Cyclops especially in areas with high endemicity of these infections. 
c) Skin 
 The children should be encouraged to wear shoes while playing in the field which are 
likely to be contaminated with infected faeces. They should not run bare feet in the open 
field. 
 
d) Diminishing the reservoir of infection 
 The water used for drinking should be protected from contamination from excreta and 
other contaminants. Men should not be allowed to bath in the wells used for drinking water. 
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Health Education 
1) Personal hygiene: 
1. The habit of washing hands after defecation and before taking food should be  encouraged. 
2. Nails should be cut and cleaned daily with soap and brush. 
3. The children should be prevented from scratching perianal region. Irritation and itching 
should be prevented by the use of antiprurite cream. 
2) Publicity: 
 The information on the mode of infection with the helminths and methods of 
prevention and treatment should be widely disseminated. 
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DRUG REVIEW 
 
jPuNt rfyNeha; jPuf;NfS 
 rPufj;Njh ljpkJuk; fhkg;g+Tk; 
rhukhk; fUQ;rPu fk;rd;dytq;fk; 
 rjFg;ig tiftiff;Fg; gye;jhndhd;W 
$uNt rh;f;fiuAk; MWgyQ;nrhd;Ndhk; 
 nfhj;Jky;yp gykhWk; rkdha;f;$l;br; 
NrUNk tifnad;d gd;dpuz;lhr;R 
 rPdpfw; fz;Lgyk; gd;dpuz;lhk;. 
 
 
gd;dpuz;Lk; ntt;NtNw apbj;Jxd;wha;g; 
 ghq;fhd fhrpnad;w NkUtpNymilj;J 
cd;dpNa ntUfbJ}s; me;jpre;jp 
 Ald;nfhs;S xUNeuk; nte;ePh;nfhs;S 
Fd;dhJ rhPukJ jplkjhFk; 
 FiynahpT neQ;Rtyp neQ;RjplkhFk; 
cd;dpNa rpuRNeh nay;yhe;jPUk; 
 XLNk gpj;jnkhL Gul;ly;eP&uy; 
fz;zpy;ePh;g; gha;r;ry;mWk; gpufhrkhFk; 
 fyq;fhJ Gj;jpaJd; khjk;jPUk;. 
 
jPUNk epj;jpiuAQ; RfKz;lhFk; 
 jPuhj GOf;fpUkp Nrug;NghFk; 
thUNk apLg;Gtyp fy;yilg;G 
 tha;f;Nfhzy; tha;f;FsW khe;jgpj;jk; 
jPUNk nrtpNehAk; nrtpLCik 
 Nrj;JkKk; gpy;ypnahL tQ;ridAe;jPUk; 
rhhpLNk njhz;ilg;Gz; fz;lkhiy 
 rhPuj;jpy; ePh;f;fl;Lk; rhh;e;JNghNk. 
  - gpuk;kKdp fUf;fil #j;jpuk; 380 
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KUDALKIRUMI CHOORNAM: 
INGREDIENTS: 
· Adhimadhuram (Glycyrrhiza glabra )   - 35 gm (1 palam)      
· Cheeragam     (Cuminum cyminum   )   - 35 gm (1 palam) 
· Madhanakamapoo(cycas circinalis)   - 35 gm  (1 palam)               
· Karuncheeragam (Nigella sativa  )    - 35 gm ( 1 palam) 
· channa Lavangam (Syzygium aromaticum )                      - 35 gm (1 palam ) 
· Sadhakuppai  (Anethum graveolens )                                 - 35 gm (1 palam)  
· Kothamalli (Coriandrum sativum )   - 210 gm ( 6palam) 
· Sarkarai       - 210 gm  (6palam)  
· Cheena  karkandu  (White sugar candy (11))  - 420  gm (12palam) 
 
 
METHOD OF PURIFICATION & PREPARATION : 
PURIFICATION METHOD: 
v Sadhakuppai , Cheeragam,  Karuncheeragam ,   Kothamalli – dried in 
sun light 
v Channa Lavangam – remove the flower bud and dried in sun light. 
v Adhimadhuram – remove the outer layer of the root and cut in to small 
pieces &dried it sun light. 
v Madhanakapoo-grind with milk and dried in sunlight and make a fry of 
it. 
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PREPARATION METHOD : 
Except Cheeni karkandu (white sugar candy ) and sarkarai all the drugs are purified, 
made into fine powder  and then finally mixed with cheena karkandu and  sarkarai. 
  DOSAGE:  
                      3-4 years -500 mg 
                      5-8years -750 mg 
                      9-12 years -1 gm   
 
 
PROPERTIES OF THE INDIVIDUAL DRUG 
1. rjFg;ig : 
Botanical name : Anethum graveolens.Linn 
Family : Umbelliferae 
NtW ngah; : Nrhapf;fPiu tpij, kJhpif. 
gad;gLk; cWg;G : tpij 
Rit : ,dpg;Gk;, fhh;g;G 
jd;ik : ntg;gk; 
gphpT : fhh;g;G 
nra;if : mfl;Ltha;tfw;wp> grpj;jPj;J}z;b, tPf;fKUf;fp 
rpWePh;ngUf;fp ,UJTz;lhf;fp, ntg;gKz;lhf;fp, ,rptfw;wp. 
nghJFzk; : 
  “thjnkhL #jpfh thjk; rpuRNeha; 
  NkhJnrtp Neha; Neha;fgNeha; - XJfpd;w 
  %yf; fLg;G Kjph;gpdrk; NghFk; 
  Qhyr; rjFg;ig ehL”. 
   - Fzghlk; %ypif tFg;G 
nghUs;: 
 ,jdhy; tspNeha; FUjpg;ngUf;fp jiytyp fhJtyp %f;FePh;gha;jy; 
fPo;tha;f;fLg;G ,itfs; ePq;Fk;. ,J grpia cz;lhf;Fk;. <uy; EiuaPuy; 
,itfspYs;s rpf;fiy mWj;J td;ikiaf; nfhLf;Fk;. 
Chemical constituents: 
 Dried ripe dill fruits contain a volatile oil and fixed oil. The volatile essential oil is 
composed of Anethine, Phellandrene and d-limonene and apiol. 
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2. ew;rPufk;: 
Botanical name : Cuminum cyminum. 
Family : Umbelliferae 
NtW ngah; : mir rPhp, cgFk;ggPrk, ; ew;rPhp, Jj;jrhk;gyk; 
gpuj;jp-tpfh ,gpj;jehrpdpNghrdFlhhp, Nkj;jpak;. 
gad;gLk; cWg;G : tpij 
Rit : fhh;g;G ,dpg;Gk; 
jd;ik : jl;gk; 
gphpT : ,dpg;Gk; 
nra;if : mfl;Ltha;tfw;wp> grpj;jPj;J}z;b 
ntg;gKz;lhf;fp Jth;g;gp. 
nghJ Fzk;: 
  “the;jp aUrpFd;kk; tha;NehagP ypfkpiug; 
  Nghw;wpUky; fy;yilg;gp yhQrdKl; Nrh;e;jfk;ky; 
  MrdF lhhpnaDk; me;jf; fpufzpAk; 
  NghrdF lhhpAz;zg; Nghk;”. 
  - Fzghlk; %ypif tFg;G 
nghUs;: 
 ,jdhy; moy; Nghk;. tapw;Wtyp tha;Neha; <uy; Neha; fhrk; fy;yilg;G 
FUjpf;fopr;ry; ,iug;G fk;ky; %f;FePh; gha;jy ntwp tspNeha; ,it tpyFk.; ,/J 
clYf;F tYitj; je;J, fz;Zf;Ff; Fsph;r;rpiaAk; cz;Lgz;Zk;. 
Chemical constituents: 
 The main chemical components of cumin oil are cuminic, cymene, dipentene, 
limonene, phellandrene and pinene. 
ACTIONS: 
 Cuminum Cyminum have anthelmintic and constipating  activity. 
 
3.fUQ;rPufk ; 
Botanical Name : Nigella sativa Linn 
Family : Ranunculaceae 
NtW ngah; : muzk;> cgFQ;rpif 
gad;gLk; cWg;G : tpij 
Rit : ifg;G> jd;ik – ntg;gk;> gphpT - fhh;g;G. 
nra;if : fpUkpehrpdp> mfl;Ltha;tfw;wp> grpj;jpj;J}z;b> 
rpWePh;ngUf;fp> twl;rpafw;wp. 
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nghJf;Fzk;: 
  “fUQ;rPufj;jhd; fug;gndhL Gz;Zk; 
  tQ;rpuha;g gPerK khw;Wk; - mUe;jpdhy; 
  fha;r;ry; jiytypAq; fz;typAk; NghKyfpy; 
  tha;r;r kUe;njdNt it”. 
  - Fzghlk; %ypif tFg;G 
nghUs;: 
 ,jdhy; kz;ilf;fug;ghd;> Gz;> cl;#L> jiyNeha;> rpuq;F> 
tapw;Wg;nghUky;> Fd;kk;> ,Uky;> the;jp> ePq;Fk;. 
Chemical Constituents: 
 Volatile oil, Fixed oil, Essential oil, albumin, sugar, organic acids, metarbin, 
arabic acid carvone, terpene, cymene seeds form a very useful remedy in worms. 
 
4. mjpkJuk; : 
Botanical Name : Glycyrrhiza glabra,Linn. 
Family : Papilionaceae. 
NtW ngah; : mjpq;fk;, ml;b (m\;b), kJ}fk;, Fd;wp Nth;. 
gad;gLk; cWg;G : Nth; 
Rit : ,dpg;G 
jd;ik : rPjk;. 
gphpT : ,dpg;G 
nra;if : twl;rpafw;wp, cs;soyhw;wp, Nfhioafw;wp, kykpyf;fp, cukhf;fp. 
Fzk; : 
  “fj;jpahp Kg;gpzpahy; tUGz; jhfq; 
  fz;Nzha;cd; khjk;tpf;fy; typntz; Fl;lk; 
  gpj;jknkYk; GUf;fp fphpr;ruk; Mth;j;j 
  gpj;jkj %h;r;ir tpl ghfk; ntg;ge; 
  jj;jptU thjNrh zpjq;fh khiy 
  rUtytplq; fhkpaNeha; jhJ el;lq; 
  Fj;jpUky; Mrpaq;fk; ,jo;Neha; ,e;J 
  Fag;GZk;Nghk; kJ}fnkdf; $Wq; fhNy”. 
  - Fzghlk; %ypif tFg;G 
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gz;G : 
 ,J Kg;gzpahy; tUk; Gz, ; ePh; Ntl;if, fz; Neha;fs, ntwp Neha;, 
tpf;fy ,ntz;Gs;sp (ntzFl;lk;),vYk;G gw;wpa Neha;, rpWePh; vhpr;ry, ;eQ;Rfs, 
fhkhiy, ntg;G Neha;fs; vd;Dk; Neha;fspd; td;ikiaf; Fiwf;Fk;. 
Iaj;jhYz;lhd Nfhioia ,sfr; nra;Ak;. jPf;Fw;wj;jpd; td;ikiaj; jhor; 
nra;Ak;. 
Chemical Constituents: 
 The main constituents are glycyrrhizin, the potassium and calcium salts of 
glycyrrhitinic acid. Flavonoid rich fractions include liquirtin, isoliquertin, liquiritigenin 
and rhamnoliquirilin. Bark contains a small quantity of Tannin. 
 
5. nfhj;Jky;yp: 
Botanical name : Coriandrum sativum,Linn. 
Family : Umbelliferae. 
NtW ngah; : cUs; muprp, jdpah. 
gad; gLk; cWg;G : tpij 
Rit : fhh;g;G 
jd;ik : ntg;gk; 
gphpT : fhh;g;G 
nra;if : mfl;Ltha;tfw;wp> grpj;jPj;J}z;b, ntg;gKz;lhf;fp, 
rPWePh; ngUf;fp. 
 
nghJ Fzk;: 
  “nfhj;Jky;yp ntg;gk; Fsph;fha;r;ry; gpj;jke;jQ; 
  rh;j;jptpf;fy; jhfnkhL jhJel;lk;- fj;jpnaOk; 
  thj tpfhh;klh; td;fh;j;j gptpuzk; 
  g+jyj;jpy; yhjfw;Wk; Nghw;W”. (m.F) 
nghUs;: 
 ,jdhy; cl;#L, esph;r;Ruk;, gapj;jpaNeha;, nrhpahik, the;jp, tpf;fy;, 
ehtwl;rp, ngU Vg;gk;, Gz; ,itfs; Nghk;. 
Chemical constituents: 
 The main chemical components are borneol, linalool, cineole, cymene, terpineol, 
dipentene, phellandrene, pinene and terpinolene. 
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6. rd;d ,ytq;fk;: 
Botanical Name : Syzygium aromaticum (Linn) Messill & Perry. 
Family : Zingiberraceae 
NtWngah; : mQ;Rfk;> cw;flk;> fUtha;f;fpuhk;G> Nrhrk;> jpusp> 
tuhq;fk;. 
Rit : fhuk;> tpWtpWg;G 
jd;ik : ntg;gk; 
gphpT : fhh;g;G 
nra;if : ,rptfw;wp> mfl;Ltha;tfw;wp> grpj;jPj;J}z;b 
nghJFzk;: 
  “gpj;jkaf;fk; NgjpNahL the;jpAk; Nghk; 
  Rj;jtpuj; jf;fLg;Ge; Njhd;WNkh – nkj;j 
  ,ytq;fq; nfhz;ltUf; Nfw; RfkhFk; 
  kykq;Nf fl;Lnkd tho;j;J. 
  Rf;fpyel; lq;fhz #u;tpaq;f yhQ;rde;jhl; 
  rpf;fy;tplhr; rh;th rpag;gpzpA - kf;fpf;Fl; 
  lq;fg; g+NthL jhpglUe; Njhd;wpypy; 
  tq;fg;g+ NthLiuj;J th.”  - Fzghlk; %ypif tFg;G 
Fzk;: 
 ,jdhy; kaf;fk;> Ngjp> the;jp> FUjpf;fopr;ry;> ehl;gl;l fopr;ry;> 
vUtha;fLg;G nrtp Neha; rpte;jkr;rk; fWj;j kr;rk; fz;zpy; g+ gilfs; 
Mfpatw;iw ePq;Fk;. 
Chemical constituents: 
 It contains Eugenol, Eugenol autate, farnesol, farnesene, asarone. 
ACTIONS: 
 Syzygium aromaticum have stomachic and antihelmintic activity. 
7.kjdfhkg;g+: 
 Botanical name:cycas circinalis.Linn 
 Family name:Cycadaceae 
NtWngah;: fhkg;g+ kjdfhNkRug;g+ kjdfhkpag;g+ 
Rit : ,dpg;G 
jd;ik :; jl;gk; 
gphpT : ,dpg;G 
nra;if : Jap;yhf;fp , Mz;ikngUf;fp, ntg;gKz;lhf;fp 
Fzk;: 
 ,jdhy; clw;F,td;ikiaAk;, Mz;ikiaAk;,jUk;.  
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8. rPdpf;fw;fz;L: 
ACCORDING TO T.V. SAMBASIVAM PILLAI AGARADHI: Vol.IV 
rPdpf;fw;fz;L Rj;jp nra;j ntz;ikahd fw;fz;L.(White sugar candy) 
rh;f;fiu nfhz;L fw;fz;L nra;ag;gLk;. 
Rit : ,dpg;G 
jd;ik : rPjk; 
gphpT : ,dpg;G 
nghJ Fzk;: 
  “<wpd; jbg;G kpUkYk;gy; the;jpfSQ; 
  rPWfg Kl;bdKQ; NruhNj – Njwpaew; 
  nrhw;fz; bsq;Fapy;fs; #o kltdNk 
  fw;fz; nldTiuf;Fq; fhy”; 
- Fzghlk; %ypif tFg;G 
nghUs;: 
,jdhy; gy;yuiz (<W jbg;G), ,Uky;, the;jp, [a moy; jPUk;. 
White sugar candy: 
Candy, specifically, sugar candy is a confection made from a concentrated 
solution of sugar in water. Only the highest quality of sugar solution is used to produce White 
candy sugar. 
Specification: 
Colour : Sparkling white 
Odour : Nil 
Sucrose : 99.90% 
Moisture : 0.05% 
Uses: 
· It is used in number of preparation of medicine. 
· It is used as remedy for sore throat 
9.Óå¢ r®¡fiu: 
Botanical Name : Saccharum officinarum.Linn 
Family                : Gramineae 
Eng.name           : Sugarcane,noble cane 
Parts used          :  Root 
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ORGANOLEPTIC CHARECTERS 
Taste         : Inippu 
Potency       :  Seetham. 
Pirivu                  : Inippu 
 "Óå¢r®¡fiu¡F¤ Ôuhjh t‹RuK§ 
 jâ¡F« thj¤Â‹ T£LwÎ« Våw;F« 
 thªÂbahL »Uä khwhjh é¡fYnk 
 bghªÂifia é£L¥ òu©L" 
 ,jdhy; thjRu«, thjNeha;, thªÂ, Ez;òO é¡fY« ngh¡F«. 
ACTIONS: 
 Antidote,Antiseptic,Antivinous,bacterial,cardiotonic,demulcent,diuretic,emollient,coo
ling, laxative,stimulant. 
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4. Materials and Methods 
4.1 Preparation of Kudal Kirumi Chooranum 
 The required drugs for preparation of KUDALKIRUMI CHOORNAM were 
purchased from a well reputed country shop and raw drugs were authenticated by the help of   
Dept HOD and Herbal botanist and with Department of Gunapadam. The  medicine  was 
prepared in Gunapadam lab of National institute of Siddha after proper purification. The 
prepared medicine  was also authenticated by the  Head of the Department. 
INGREDIENTS: 
· Adhimadhuram (Glycyrrhiza glabra )  - 35 gm (1 palam)      
· Cheeragam     (Cuminum cyminum   )  - 35 gm (1 palam) 
· Madhanakamapoo(cycas circinalis)  - 35 gm  (1 palam)               
· Karuncheeragam (Nigella sativa  )   - 35 gm ( 1 palam) 
· channa lavangam (Syzygium aromaticum )           - 35 gm (1 palam ) 
· Sadhakuppai  (Anethum graveolens )                     - 35 gm (1 palam)  
· Kothamalli (Coriandrum sativum )  - 210 gm ( 6palam) 
· Sarkarai      - 210 gm  (6palam)  
· Cheena  karkandu  (White sugar candy (11)) - 420  gm (12palam) 
METHOD OF PURIFICATION & PREPARATION : 
PURIFICATION METHOD: 
v Sadhakuppai , Cheeragam,  Karuncheeragam ,   Kothamalli – dried in 
sun light 
v channalavangam – remove the flower bud and dried in sun light. 
v Adhimadhuram – remove the outer layer of the root and cut in to small 
pieces &dried it sun light. 
v Madhanakapoo-grind with milk and dried in sunlight and make a fry of 
it. 
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PREPARATION METHOD : 
Except Cheeni karkandu (white sugar candy ) and sarkarai all the drugs are purified, 
made into fine powder  and then finally mixed with cheena karkandu and  sarkarai. 
  DOSAGE:  
                      3-4 years -500 mg 
                      5-8years -750 mg 
                      9-12 years -1 gm   
Dose calculation for pediatric group is based on Height and Weight chart, ICMR, 1990; and 
the formula mentioned in the Essential of medical pharmacology by K.D. Tripathi    
ADJUVANT: HOT WATER  
DURATION: 7 days 
DRUG STORAGE:  
      The trial drug KUDALKIRUMI CHOORANAM is  stored in clean and dry air tight 
container. 
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SADHAKUPPAI - ANETHUM   GRAVEOLENS 
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4.2 Preclinical studies 
4.2.1 Preliminary phytochemical screening of KKC 
             
The preliminary qualitative phytochemical screening of KKC was done by the method of  
Kolkate  
S. NO Procedure 
1 Test for Sulphate : 2 ml of the extract is added to 5 % barium chloride solution. 
2 Test for Chloride : The extract is treated with Silver nitrate solution  
3 Test for carbonate : The substance is treated with Conc. HCl. 
4 Test for Starch : The extract is added with weak iodine solution  
5 Test for Iron (Ferric) : The extract is treated with glacial acetic acid and 
potassium ferrocyanide  
6 Test for Calcium : 2 ml of extract is taken in a clean test tube. To this add 2 ml 
of  4% ammonium oxide solution.   
7 Test for Iron (Ferrous) : The extract is treated with Conc. HNO3 and 
ammonium thiocynate 
8 Test for phosphate : The extract is treated with ammonium molybdate and conc. 
HNO3 
9 Test for Tannic acid : The extract is treated with Ferric chloride  
10 Test for Unsaturation : 1 ml of Potassium permanganate solution is added to 
the extract.    
11 Test for saponins: Dilute extract+ 1ml of distilled water shake well. 
12 Test for sugars :  
 Benedict method ; 5ml of  Benedict solution heated gently then add 8 drops of 
diluted extract then heated in a boiling water bath. 
Molisch test; Dilute extract+2 drops of Molisch+3ml conc.H2SO4. 
13 Test for steroids : Liberman Burchard test ; Dilute extract +2 ml acetic 
anhydride+conc.H2SO4 . 
14 Test for amino acids: Dilute extract +2ml of Ninhydrin’s soln . 
15 Test for proteins: Biuret method ; 1ml of dilute extract+1mlof5%CuSO4+ 
1%NaOH. 
16 Test for Flavanoids : Dilute extract+ mg  bits+2drops of conc.HCl  and gently 
heated. 
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17 Test for phenol; Dilute extract+2drops of FeCl3 soln. 
18 Test for Tannins ; dilute extract +2ml of 10%lead acetate add. 
19 Test for alkaloids; 
 Mayer’s method;1ml of dilute extract + 1ml reagent. 
Dragendroff’s method; 1ml of dilute extract+ 1ml of reagent. 
 
 
4.2.2 Toxicity studies 
 The preclinical studies for acute toxicity was carried out in  pharmacological 
laboratory in National institute of Siddha with the reference number of IAEC protocol 
no:1248/ac/09/CPCSEA and subacute toxicity studies were done in C.L.BAID MEHTA 
COLLEGE OF PHARMACY. 
 
4.2.2.1 Drugs and chemicals 
 Fine chemicals used in these experiments were obtained from Sigma Chemicals 
Company, U.S.A. Other analytical grade chemicals were obtained from S.d. Fine Chemicals 
Ltd., Mumbai. Standard drug   Albendazole was procured from the market. 
 
4.2.2.2 Experimental animals 
  Colony inbred wistar rats of either sex weighing 200 - 250 g were used for the 
pharmacological and toxicological studies. The animals were kept under standard conditions 
12:12 (day/night cycles) at 220C room temperature, in polypropylene cages. The animals 
were fed on standard pelleted diet (TANUVAS,Chennai) and tap water ad libitum. The 
animals were housed for one week in polypropylene cages prior to the experiments to 
acclimatize to laboratory conditions. The experimental protocol was approved by the 
Institutional Animal Ethical Committee (IAEC).(IAEC/XXXV/93/CLBMCP/2012) 
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4.2.2.3 Acute oral toxicity study     
 Acute oral toxicity was conducted as per the OECD guidelines (Organization of 
Economic Cooperation and Development) 423 (Acute Toxic Class Method). The acute toxic 
class method is a stepwise procedure with 3 animals of a single sex per step. Depending on 
the mortality and /or moribund status of the animals, on the average 2-4 steps may be 
necessary to allow judgment on the acute toxicity of the test substance. This procedure results 
in the use of a minimal number of animals while allowing for acceptable data based scientific 
conclusion. The method uses defined doses (5, 50, 300, 2000 mg/kg body weight) and the 
results allow a substance to be ranked and classified according to the Globally Harmonized 
System (GHS) for the classification of chemicals which cause acute toxicity. Female Wistar 
albino rats weighing 200-250 g were fasted overnight, but allowed water ad libitum. Wistar 
albino rats of either sex weighing 200-250 g were fasted overnight, but allowed water ad 
libitum. Since the formulation is relatively nontoxic in clinical practice the highest dose of 
2000 mg/kg/p.o (as per OECD guidelines “Unclassified”) was used in the acute toxicity 
study.  The animals were observed closely for behavioral toxicity, if any by using FOB 
(Functional observation battery). 
4.2.2.4 Repeated oral toxicity study  
 Repeated oral toxicity studies can be used to get additional information regarding the 
toxicity profile of a chemical. Repeated oral toxicity studies are defined as those studies 
where the chemical is administered to the animal for a period covering approximately 10% of 
the expected life of the animal. Usually, the dose levels are lower than for acute studies and 
allow chemicals to accumulate in the body before lethality occurs, if the chemical possess 
this ability. 
4.2.2.5 Experimental procedure 
 The following experimental procedure was followed to evaluate the repeated oral 
toxicity study of  KKC 
 
Group I : Control animals received 1%CMC, 2 ml/kg/p.o. for  14 days  
Group II : Received KKC  at the dose of  135mg/kg/po in 1%CMC for  14 days 
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 The dose for rats was calculated by multiplying the daily dose used in the clinical 
practice( i.e.750mg BID=1500mg/day) divided by a factor 0.018 corresponding to the body 
surface area  of man weighing 70kg to rat weighing 200g. 
 Single dose 750mg,  Daily dose 1500mg x 0.018 =27mg for a rat weighing 200g.  
Multiply the rat dose for a rat weighing 200g x5 to get the dose for kg/body weight of rat 
(i.e.27mg x 5=135mg/kg/po) 
       Body weight, food intake and water intake was recorded at two intervals with 
simultaneous observation for toxic manifestation and mortality, if any. At the end of 28 days 
treatment blood samples were collected by retro orbital puncture and used for hematological 
studies and serum was used for biochemical studies  
4.2.2.6 Biochemical studies 
Aspartate aminotransferase (AST) - Aspartate aminotransferase was estimated 
using commercial AST kit (Span Diagnostics) by the method of (2). 
Alanine aminotransferase (ALT) - Alanine aminotransferase was estimated using 
commercial AST kit (Span Diagnostics) by the method of Reitman(2). 
 Alkaline phosphatase (ALP)- Alkaline phosphatase was assayed using commercial 
ALP kit (Span Diagnostics)  by the method of King (3) 
4.2.2.7 Hematological studies 
 
Erythrocyte count - Erythrocyte count was estimated by Hem cytometer method of 
Ghai (4). 
Total Leukocyte Count (WBC) - Total Leukocyte Count was estimated by Hem 
cytometer method of John (5) 
Hemoglobin - Hemoglobin was estimated by method of Ghai (4). 
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4.2.3 Anthelminthic activity 
 
Adult  Ascaris  were collected from the abomasum of sheep slaughtered at the  corporation 
Abattoir Chennai.  Immediately after slaughter, the abomasum were collected and transported 
to the laboratory. The parasites were then collected, washed and kept in phosphate buffered 
saline (PBS). The experiment was conducted according to Eguale et al . (6) Ten actively 
moving worms were placed in Petri dishes containing the desired concentration of the test, 
standard drug s in DMSO+ PBS mixture and DMSO+ PBS alone for the control group.. 
Albendazole dissolved in DMSO and diluted in PBS at concentrations of 0.5 mg/ ml was 
used as the positive control. Three replications per each treatment concentration were 
employed. After 24 hours, the test drug and albendazole were washed away and the parasites 
suspended in PBS for 30 minutes for possible recovery of parasite motility. The number of 
motile (alive) and immotile (dead) worms were counted under the dissecting microscope, and 
recorded for drug concentrations. Death and paralysis of worms was ascertained by the 
observations made as tabulated below. Anthelminthic assessment-distinction between 
paralysis and death of worms 
 
Parameters Description with drugs Description with control 
Paralysis Marked decrease in vigorous 
wriggling movement of the 
worms indicate Paralysis 
with test drugs Evoked pin 
prick  response shows 
movement of the worm after 
being pricked with pin 
indicates paralysis 
No change in the motility and 
all worms are active 
Mortality No movement indicates 
death. Further confirmation 
by dipping the worms in 
warm water 50 degree and 
shaken vigourosly.No 
response indicates death 
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4.2.4 Laxative effect 
Rats were fasted overnight and the drug and Agar-agar were administered in the morning. 
After 8hrs of drug administration the feces were collected and wet weight was recorded. 
Thereafter food and water were given to all groups of animals and fecal output was again 
taken at the end of 16th hr. Wet weight of the feces was recorded. The mean values(n=6) was 
calculated and the laxative effect was compared with the agar-agar group.  
4.3 Clinical studies 
Kudal kirumi is one of the frequently encountered problem among young children. A  
protocol was prepared and submitted before IEC meeting, a copy of  which is attached as 
annexure-1. After that 40 cases were selected for clinical trial from the OPD and IPD of 
Kuzhandhai Maruthuvam department National institute of Siddha. 
 
 
STUDY DESIGN & CONDUCT OF STUDY: 
Study type: An   open clinical trial 
Study place: OPD &IPD Of Ayothidoss pandithar hospital, National Institute of 
Siddha,Tambaram sanatorium, Chennai - 47 
Study period: 12 months 
POPULATION AND SAMPLE :    
· The population consists of paediatric patients attending the OPD of Ayothidoss 
Pandithar Hospital, National Institute of Siddha, Chennai-47. 
· The sample consists of 3 – 12 yrs  age group fulfilling all the inclusion criteria and  
the exclusion criteria. 
Sample size : 40 Patients     
SUBJECT SELECTION 
               As and when patients  reporting with symptoms of inclusion criteria will be 
subjected  to screening  test and they will be included in this study by  using screening 
proforma . 
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INCLUSION CRITERIA: 
· Age :Between 3 to 12 years. 
· Sex : Both male and female child. 
· Having complaints of loss of appetite . 
· History of passing worms in the stools. 
· Presence of peri anal itching . 
· Pain around the umbilicus. 
· Teeth grinding during sleep (Bruxism ) 
· Willing to give both blood and motion specimen for investigation, when required 
 EXCLUSION CRITERIA: 
· Children below 3 yrs age 
· Patient with chronic diseases like primary complex, chronic renal failureetc.,  
· Patients not willing to give blood and  motion sample for investigation  
· Enteric fever 
· Amoebiasis 
· Diarrhoea 
WITHDRAWAL CRITERIA: 
· Signs of profuse dehydration. 
· Poor patient compliance. 
· Patient turned unwilling to continue in the course of clinical trial. 
· Occurrence of any adverse reaction 
· Onset of explosive foul smelling diarrhoea  
·  Extra intestinal complications  
  
63 
 
 The trial drug “KUDALKIRUMI  CHOORANAM” will be given continuously for 7 
days. On the 8th day patient will be  requested to attend the OPD for clinical assessment and it 
will be  recorded in the clinical assessment form and prognosis noted ..The patient’s 
informant are requested to bring back the un-consumed trial drug if any. For IP patients the 
drug will be provided daily and prognosis  noted.Laboratory investigations  will be done on 0 
day & 15th day of the trial are recorded.  After the completion of the treatment, the patient is 
advised to visit the OPD  for another 1 months for follow-up. If any trial patient who fails to 
collect the trial drug on the prescribed day but wants to continue in the trial from the next day 
or two, he/ she will be allowed, but defaulters of one week and more will not be allowed to 
continue and be withdrawn from the study with fresh case being inducted. 
DISPENSING 
       The KUDALKIRUM CHOORNAM  is given in powder form as separate pockets of 
individual dose in a ziplock cover. 
 
ASSESMENTS AND TESTS  
A. Clinical assessment proforma 
B. Routine investigations 
C. Specific investigations 
D. Siddha method of assessment 
 
 
A. CLINICAL ASSESSMENT PROFORMA 
· Pain around the umbilicus, 
· Nausea, 
· Loss of appetite, 
· Disturbed sleep with grinding teeth, 
· Perianal itching. 
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Blood  Investigations  
· HB 
· Total WBC Count 
· DC-  Polymorphs 
· Lymphocytes  
· Eosinophils  
· Monocytes  
· Basophils  
· Total RBC count  
· ESR 
URINE 
       Albumin 
       Deposits 
 
SPECIFIC INVESTGATIONS 
MOTION TEST (ZINC SULPHATE METHOD) 
             OVA, CYST, OCCULT BLOOD 
 
SIDDHA METHOD OF ASSESSMENT :Nilam, Kalam, Uyirthathukkal, Udal thathukkal, 
Envagai thervugal(10). 
 
 STUDY ENROLLMENT : 
· In this pilot open clinical trial, patients reporting at the OPD with the clinical 
symptoms of  presence of peri anal itching, loss of appetite, pain around the 
umbilicus, teeth  grinding during sleep (Bruxism) will  be examined clinically for 
enrolling in the study based on the inclusion and exclusion criteria.  
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· The patients who are to be enrolled would be informed  about the study, trial drug, 
possible outcomes and the objectives of the study in the language and terms 
understandable to patient’s informant 
· After ascertaining the patient’s informant willingness, informed consent would be 
obtained in writing from them in the consent form (Form II). 
· All these patients were given unique registration card in which patients’ 
Registration number of the study, Address, Phone number and Doctors phone 
number etc. will be given, so as to report  easily should any complications arise. 
· Complete clinical history, complaints and duration, examination findings all would 
be recorded in the prescribed Proforma in the history and clinical assessment forms 
separately.  
· Patients would be advised to take the trial drug and appropriate dietary advice 
would be given according to the patient’s informant perfect understanding.         
 DATA MANAGEMENT: 
· After enrolling the patient in the study, a separate file for each patient will be 
opened and all forms will be filed in the file. Study No. and Patient No. will be 
entered on the top of file for easy identification. Whenever study patient visits OPD 
during the study period, the respective patient file will be taken and necessary 
recordings will be made at the assessment form or other suitable form. 
· The screening forms will be filed separately. 
· The Data recordings in all forms will be monitored and scrutinized by HOD, Dept 
of kuzhanthai maruthuvam . 
· Data analysis will be done with the help of senior research officer (statistics) of 
NIS. 
 
OUTCOME : 
 Good:Absence of ova,cyst in motion investigations & symptoms reduced  
 Completely.  
 Poor:presence of  ova,cyst in motion investigations. 
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ADVERSE EFFECT/SERIOUS EFFECT MANAGEMENT: 
                      If the trial patient develops any adverse reaction, he/she would be immedietly 
withdrawn from the trial and proper management will be given in OPD of National institute 
of siddha and the same will be reported to regional pharmacovigilance centre.                                          
ETHICAL ISSUES 
 1. To prevent any infection, while collecting blood sample from the patient, only 
disposable syringes, disposable gloves, with proper sterilization of lab    equipments will  be 
used.                          
2. No other external or internal medicines will be used. There will be no infringement on the 
rights of patient.  
3.The data collected from the patient’s informant will be kept confidentially. The  
   patient’s informant will be Informed  about the diagnosis, treatment and follow-up.  
4. After the consent of the patient’s informant (through consent form), patient will be  
 enrolled in the study.  
5 Informed consent will be obtained from the patient’s informant explaining in the  
 understandable language to the patient’s informant. 
6.Treatment would be provided free of cost. 
7.In conditions of treatment failure , adverse reactions, patients will be given              
 alternative treatment at the National Institute of Siddha with full care. 
ASSESSMENT  FORM 
FORM I        SCREENING & SELECTION PROFORMA 
FORM II       CONSENT  FORM 
FORM III      HISTORY PROFORMA 
FORM IV      CLINICAL ASSESSMENT  FORM 
FORM V       LABORATORY INVESTIGATION  FORM 
FORM VI      PATIENT INFORMATION SHEET 
FORM VII    WITHDRAWAL FORM  
FORM VIII   ADVERSE EFFECT FORM 
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PATIENT SCREENING 
 
INCLUSION / EXCLUSION 
INCLUSION 
CRITERIA EXCLUSION 
CRITERIA 
 EXCLUDED FROM 
TRIAL 
METHODOLOGY 
       STUDY NUMBER 
     HISTORY TAKING 
LAB INVESTIGATION 
 TRIAL DRUG  
GIVE GENERAL 
TREATMENT 
CLINICAL ASSESSMENT 
OUTCOME 
INFORM ABOUT STUDY 
AND TRIAL DRUG 
 INFORMED COSENT 
FORM 
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5. OBSERVATION AND RESULTS 
5.1 Preliminary phytochemical screening of KKC 
 
The pre clinical qualitative phytochemical analysis of KKC showed the following results 
Inference Observation 
Absence of calcium  No white precipitate is formed 
Absence of Sulphate  No white precipitate is formed  
Presence of Chloride  White precipitate is formed 
Absence of carbonate No effervescence is formed  
Absence of starch  No blue colour is formed 
Absence of Ferric iron No blue colour is formed 
Presence of Ferrous iron Blood red colour is formed 
Presence of phosphate Yellow precipitate is formed 
Presence of Tannic acid Black precipitate is formed 
Absence of unsaturated compound Does not get decolourised  
Absence of saponins No Froth formation 
Indicates the Absence of sugar No colour change occured    
Absence of carbohydrate No Reddish violet zones appeared 
Absence of steroids No Formation of red colour  
Presence of  amino acids Formation of  violet colour 
Presence of proteins Formation of deep blue  colour 
Presence of Flavanoids Formation of pink colour 
Absence of phenols  No green colour is formed 
Presence of tannins White precipitate formed 
Presence of alkaloids Appears cream colour precipitate 
Presence of alkaloids Appears orange colour precipitate 
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5.2 Preclinical studies 
Acute oral toxicity study 
           
 KKCat the dose of 2000mg/kg/po did not exhibit mortality in rats., hence further 
study with higher dose was not performed with KKC.According to OECD guidelines the drug 
is identified as “Unclassified “under the toxicity scale.  
 
Repeated oral toxicity for 14 days 
 Test drug KKC  at the dose of  135mg/kg/po when administered orally for 14 days in 
rats did not show significant  toxicity in Hematological(Table-2),  liver and kidney function 
tests.  
 
 
 
Groups Hb 
(gm/100ml) 
RBC 
(millions/cu
.mm) 
WBC 
(cells/cu.mm) 
Differential leucocyte count (%) 
Lympho 
Cytes 
Mono 
cytes 
Granulo 
Cytes 
Normal 13.23 ± 0.56 4.59 ± 0.565  5650.08 ± 
9.43 
76.06 ± 3.27  5.610 ± 
1.27 
19.84 ±  
4.647 
KKC135
mg/kg/po 
14.41 ± 
0.021 ns 
5.08 ± 0.021 
ns 
6035 ± 0.813 74.07 ± 1.04 
ns 
5.64 ± 
0.58 ns  
20.06 ± 3.31 
ns 
 
n=6; Values are expressed as mean ± S.E followed by Students Paired ‘T’ Test 
ns – Non significant when compared to control group 
Effect of Siddha formulation (KKC) on Biochemical markers of liver and kidney after 
14 days repeated oral dosing (135 mg/kg/po) in rats 
 
Groups AST 
(IU/L) 
ALT 
(IU/L) 
ALP 
(IU/L) 
BUN 
(mg/dl) 
Creatinine 
(mg/dl) 
Normal 72.64 ± 
0.349 
30.64 ± 
0.821 
158.45 ± 
0.64 
30.16±1.45 0.70±0.01 
KKC(135mg/kg) 77.40 ± 
0.06ns 
32.13 ± 
0.604 ns 
154.25 
±0.45ns 
32.03±0.01ns 0.78±0.65ns 
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N=6; Values are expressed as mean ± S.E followed by Students Paired ‘t’ Test 
Ns – non significant when compared to control groups 
 
Anthelminthic activity of KKC(in vitro) study 
 After 24 hours of exposure of adult ascaris to a concentration of    to KKC, significant 
reduction in motility was observed. which was statistically significant ( P > 0.05) when 
compared to the nil death of worms recorded in the control group.KKC also showed a time 
dependent response to mortality when compared to control and Piperazine citrate, on the 
other hand killed the parasites  at a concentration   within a short time when compared to the  
test drug 
 
Time taken in minutes for paralysis and death of ascaris(round worms) in response to 
KKC and  Piperazine Citrate 
 
Treatment Time for paralysis in 
minutes 
Time for death in minutes 
Control >360mts (No paralysis) >360mts(No death) 
Piperzine citrate 9.60±0.67*** 21.54±1.03*** 
KKC 59.9±2.58*** 158.4±5.82*** 
 
Laxative effect of KKC in rats 
 
 KKC exhibited a laxative effect which was comparable to the natural laxative agar-
agar when tested in fed rats after 8 hrs. (Table-5) 
 
Treatment                           Faecal weight in grams 
 
8hrs(after drugs 
administration 
16hrs after dugs 
administration 
Control 0.851±0.45 0.813±0.55 
Agar-agar treated 5.132±1.01 5.976±0.73 
KKC treated 4.831±0.87 5.210±0.09 
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5.3 Clinical Studies  
For the clinical study 40 cases were selected and treated, in which 30 cases were 
treated in OPD and 10 cases were treated in IPD of National Institute of Siddha.  Results 
were observed with respect to the following criteria 
v Age distribution 
v Sex distribution 
v Religious distribution 
v Socio-economic status 
v Diet reference 
v Aetiological factors 
v Duration of illness 
v Paruva kaalam 
v Thinai 
v Mukkutram reference 
v Vatham 
v Pitham 
v Kabam 
v Udal kattugal 
v Envagai thervu 
v Neikuri 
v Clinical features before treatment 
v  Clinical features after treatment    
v  Results  
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1.AGE DISTRIBUTION 
 
 
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
3-4 YEARS 4-5 YEARS 5-6 YEARS 6-9 YEARS 9-12 
YEARS
22.50%
12.50%
1%
30%
25%
AGE DISTRIBUTION
AGE DISTRIBUTION
AGE(YEARS) NO OF CASES PERCENTAGE% 
 
3-4 yrs 
 
9 
 
22.5% 
4-5 yrs 5 12.5% 
5-6 yrs 4 1% 
6-9 yrs 12 30% 
9-12 yrs 10 25% 
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Inference 
In Age distribution, 9 cases (22.5%) were between 3 – 4 yrs, 5 cases (12.5%) were 
between 4-5 yrs and 4 cases (1%) were between 5-6 yrs,12 cases(30%) were between6-
9yrs,10cases(25%) were between 9-12yrs. 
There is increase incidence of kudal kirumi in the age group of 6-12 yrs. This is may 
be due to school going children are more prone to naaku puchi noi due to pica, unhygienic 
food habits, intake of contaminated water. 
2.SEX DISTRIBUTION 
 
SEX 
 
NO OF CASES 
 
PERCENTAGE% 
 
MALE   
 
17 
 
42.5% 
 
FEMALE  
 
23 
 
57.5% 
 
Inference: For this study, 40 cases were selected in which 17 cases (42.5%) were male 
children and 23 cases (57.5%) were female child 
Male child
Female child
17
42.5
23
57.5
0
10
20
30
40
50
60
Gender
No of cases
Percentage
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     3. RELIGIOUS DISTRIBUTION 
 
 
 
Inference 
In religious distribution 33 cases(95.5%) were Hindu, 1 cases (2.5%) were   Muslim, 
and 1 cases (2.5%)  were Christians.The cases registered for this study mostly belong to 
Hindu religion.  
 
         
     
38
1 1
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2.5 2.5
0
10
20
30
40
50
60
70
80
90
100
hindu muslim christian
no of cases
percentage%
Religion No of cases Percentage% 
Hindu 38 95% 
Muslim 1 2.5% 
Christian 1 2.5% 
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4. SOCIO ECONOMIC STATUS 
  
Socio economic status No of cases Percentage% 
Poor 29 72.5% 
Middle class 7 17.5% 
rich 4 10% 
 
 
Inference 
The socio-economic status chart shows that 29 cases (72.5%) come under Poor socio 
economic status, 7 cases(17.5%) come under Middle class and 4 cases(10%) come under 
Rich category. There is increase incidence of kudal kirumi in poor socio-economic status. 
This may be due to unhygienic food and water intake, lack of hygiene and over crowded 
residence. 
 
                                       
29
7
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80
poor middle class rich
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  5. DIET REFERCENCE 
 
Diet habit No of cases Percentage% 
Vegetarian 8 20% 
Non vegetarian 32 80% 
 
 
 
Inference 
Out of 40 cases, 8 cases (20%) had Vegetarian diet habit and 32 cases (80%) had 
Non-vegetarian diet habit. There is increase incidence of kudal kirumi in children having 
non-vegetarian dietary habit. This may be due to intake of improperly cooked meat and fish 
varieties
0
10
20
30
40
50
60
70
80
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Category 2
8
32
20
80
no of cases
percentage%
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6. ETIOLOGICAL FACTORS 
 
Etiological factor No of cases Percentage% 
Pica 37 92.5% 
Improperly cooked food 25 62.5% 
Drinking unsterilized water 20 50% 
Unhygienic condition 38 95% 
Over crowded houses 30 75% 
 
 
 
Inference 
Out of 40 cases, the aetiological factors in 37 cases(92.5%) were due to Pica, 25 
cases(62.5%) were due to Improperly cooked food, 20 cases(50%) were due to Unhygienic 
condition and 30 cases(75%) were due to the Over crowded houses. 
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                                     7. DURATION OF ILLNES 
  
Duration  
( months ) 
No of cases Percentage% 
1-6 40 100% 
7-12 - - 
13-24 - - 
25-36 - - 
36 and above - - 
 
 
Inference 
Out of 40 cases, all the 40 cases (100%) belong to 1-6 months duration of illness. 
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8.  PARUVA KALAM 
 
Paruvakalam No of cases Percentage% 
Kaar(aavani,purattasi) 16 40% 
Koothir(iypasi,karthigai) 15 37.5% 
Munpani(margazhi,thai) - - 
Pinpani(masi,pankuni) - - 
Elavenil(chithirai,vaikai) - - 
Mudhuvenil(aani,aadi) 9 22.5% 
 
 
Inference 
In Paruva Kaalam distribution, 16 cases (40%) belong to Kaar Kaalam, 15 cases 
(37.5%) belong to Koothir Kaalam,  and 9 cases (22.5%) belong to Mudhuvenil Kaalam. 
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9. THINAI 
Thinai No of cases Percentage % 
Kurinji(hill area) 2 5% 
Mullai(forest area) - - 
Marutham(fertile area) - - 
Neithal(coastal area) 38 95% 
Paalai(desert area) - - 
 
 
 
Inference 
In Thinai distribution, 2 cases (5%) belong to Kurinji Nilam and 38 cases (95%) 
belong to Neithal Nilam. There is increase incidence of kudal kirumi in neithal nilam. This 
may be due to unhygienic, poor sanitation and over crowded residence. 
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10. DERANGEMENT OF VATHAM 
S.no Vatham No of cases Percentage% 
1 Pranan - - 
2 Abanan 40 100% 
3 Viyanan 24 60% 
4 Uthanan 36 90% 
5 Samanan 40 100% 
6 Nagan - - 
7 Koorman                       -  
8 Kirukaran 37 92.5% 
9 Devathathan 18 45% 
10 dhananjeyan - - 
 
 
Inference 
Among 40 cases, all the 40 cases(100%) show Abanan derangement, 24 cases(60%) 
show viyanan derangement,36 cases(90%) show uthanan derangement,40 cases(100%)  show 
Samanan derangement and 37 cases(92.5%) show Kirukaran derangement, 18 cases(45%) 
show devathathan derangement. 
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11. DERANGEMENT OF PITHAM 
S.no  Pitham No of cases Percentage% 
1 Analapitham 37 92.5% 
2 Ranjagam 28 70% 
3 Saathagam - - 
4 Prasagam 18 45% 
5 Alosagam - - 
 
 
 
Inference 
Among 40 cases, all the 37 cases (92.5%) show Analapitham derangement, 28 cases 
(70%) show Ranjagam derangement & 18 cases (45%) show Prasagam derangement. 
 
37
28
0
18
92.5
70
0
45
0
10
20
30
40
50
60
70
80
90
100
analapitham ranjagam saathagam prasagam alosagam
no of cases
percentage%
  
83 
 
12. DERANGEMENT OF KABAM 
S.no Kabam No of cases Percentage% 
1 Avalambagam 37 92.5% 
2 Klethagam 37 92.5% 
3 Pothgam - - 
4 Tharpagam - - 
5 Santhigam - - 
 
 
Inference 
Out of 40 cases, 37 cases (92.5%) show Avalambagam derangement and 37 cases 
(92.5%) show Klethagam derangement 
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13. UDAL KATTUGAL 
 
S. No Udalkattugal No of cases Percentage% 
1 Saaram 40 100% 
2 Senner 35 87.5% 
3 Oon - - 
4 Kozhuppu - - 
5 Enbu - - 
6 Moolai - - 
7 Sukkilam - - 
 
 
Inference 
 Out of 40 cases, Saaram was affected in all the 40 cases (100%) and Senneer was 
affected in 35 cases (87.5%). 
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14. ENVAGAI THERVUGAL 
 
S.no Envagaithervugal No of cases Percentage% 
1 Naadi:vathapitham 
Pithavatham 
23 
17 
57.5% 
42.5% 
2 Sparisam 18 45% 
3 Naa 35 87.5% 
4 Niram - - 
5 Mozhi - - 
6 Vizhi 35 87.5 
7 Malam 40 100 
8 Moothiram - - 
 
 
Inference 
Out of 40 cases, 23 cases (57.5%) show vatha pitham Naadi and 17 cases (42.5%) 
show Pitha vatham Naadi. In 18 cases (45%) Sparisam was affected, in 35 cases (87.5%) Naa 
was affected, in 35 cases (87.5%) Vizhi was affected & in all the 40 cases (100%) Malam 
was affected 
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15. NEIKKURI 
 
Neikuri No of cases Percentage% 
Spreading like a snake 26 65% 
Spreading like a ring 11 27.5% 
Spreading like a pearl 3 7.5% 
 
 
Inference 
Among 40 cases, Vatha Neikuri (Spreading like a snake) is noted in 26 cases (65%) 
,Pitha Neikuri (Spreading like a ring) is noted in 10 cases (25%) and kaba Neikuri (Spreading 
like a pearl) is noted in 3 cases (7.5%) 
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16. CLINICAL FEATURES BEFORE TREATMENT 
 Clinical features No of cases Percentage% 
Loss of appetite 36 90% 
Peri anal itching 27 67.5% 
Worms in the faeces 27 67.5% 
Pain in the abdomen 30 75% 
Disturbed sleep 27 67.5% 
Teeths grinding 11 27.5% 
Nausea  14 35% 
 
 
Inference 
Out of 40 cases, all the 36 cases(90%) had loss of appetite, 27 cases(67.5%)  had Peri-
anal itching, 27 cases(67.5%) had the complaint of  worms in the faeces, 30 cases(75%) had 
pain in the abdomen, 27 cases(67.5%) had disturbed sleep, 11 cases(27.5%) had teeth 
grinding symptom and 14 cases(35%) had nausea. 
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17. CLINICAL FEATURES AFTER TREATMENT 
Clinical features No of cases 
With symptoms 
No Of Cases 
Relieved  
Percentage% 
Loss of appetite 36 32 88.8% 
Peri anal itching 27 22 81.4% 
Worms in the faeces 27 22 81.4% 
Pain in the abdomen 30 26 86.6% 
Disturbed sleep 27 23 85.1% 
Teeths grinding 11 8 72.7% 
Nausea  14 10 71.4% 
 
 
Inference: 
 In 40 cases, Loss of appetite was relieved in 32 cases out of 36 cases, Pain in the 
abdomen was relieved in  22cases out of 27 cases, Disturbed sleep was relieved in 23 cases 
out of 27 cases, Peri-anal itching was relieved in 22 cases out of 27 cases, Worms in the 
faeces was not found in 22 cases out of 27 cases, teeth grinding was not found in 8cases out 
of 11 cases and nausea was relieved in 10 cases out of 14 case. 
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18. RESULTS 
 
Result  No of cases Percentage% 
Good  
(Absence of ova and cyst) 
32 80% 
Poor 
(Absence of ova and cyst ) 
8 20% 
 
 
 
Inference 
Out of 40 cases selected, 32 cases (80%) show Good Improvement and 8 cases (20%) 
show Fair improvement. 
 
80%
20%
Results
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INVESTIGATION REPORTS OF BEFORE & AFTER TREATMENT FOR IP PATIENTS 
          BLOOD TEST MOTION TEST     NO 
OF 
DAYS 
          BT  AT  
  
  
 
S.N
o 
I.P  No NAME AG
E 
SEX TC DC HB ESR RBC TC DC HB ESR  RBC BT A
T 
    
 
          Cu/m
m 
gm
s 
1/2h
r 
1h
r 
Milli 
Cu/m
m 
 
Cu/m
m 
 
gm
s 
1/2h
r 
1h
r 
Milli 
Cu/m
m   
D.O.A D.O.D 
 
 
            P L E     P L E       
1 986 Jeevananadha
m 
12 MC
H 
8700 5
7 
4
0 
3 12.
5 
4 10 5.1 7200 5
8 
4
0 
2 11.
2 
3 6 5.1 Ascari
s ova 
prsent 
Nil 15.8.12 21.8.12 7 
2 1004 Dharani 7 FCH 8100 3
7 
5
4 
7 9.5 4 10 3.2 7200 5
4 
4
4 
2 10 3 6 3.5 Ascari
s ova 
prsent 
Nil 16.8.12 1.9.12 7 
3 1003 Deepika 7 FCH 11200 3
7 
5
8 
5 10.
1 
4 8 3.5 7200 5
6 
4
2 
2 9.6 2 4 3.7 Ascari
s ova 
present 
Nil 25.8.12 31.8.12 7 
4 1036 Manimegalai 4 FCH 10700 4
9  
4
5 
6 9.3 6 8 3.2 6800 5
0 
4
9 
1 10.
8 
3 6 3.5 Ascari
s ova 
present 
Nil 2.11.12 8.11.12 7 
5 1030 Nirmalkumar 10 MC
H 
7400 4
0 
5
7 
3 10 4 10 3.5 8200 5
4 
4
4 
2 11.
3 
2 8 3.6 Ascari
s ova 
present 
Nil 2.11.12 8.11.12 7 
6 1025 Priyanka 12 FCH 7300 4
0 
5
6 
4 9.4 2 8 3.5 6500 5
9 
3
9 
2 7.6 2 6 3.5 Ascari
s ova 
present 
PR 10.11.1
2 
17.11.1
2 
7 
7 1026 Prabha 12 FCH 8100 3
8 
5
7 
5 9.2 2 10 3.1 7700 5
9 
3
9 
2 11.
2 
2 8 3.1 Ascari
s ova 
present 
Nil 10.11.1
2 
17.11.1
2 
7 
8 D00949
9 
Barkavi 6 FCH 7400 3
4 
4
8 
7 10.
7 
2 4 3.7 8900 6
0 
3
7 
3 8.7 2 4 4.1 Ascari
s ova 
present 
Nil - - 7 
9 C43681 Roshini 3 FCH 9000 5
8 
4
0 
2 9.7 3 6 3.6 6800 5
9 
3
7 
4 7.3 2 4 3.2 Ascari
s ova 
present 
Nil - - 7 
10 D01024
8 
Manikandan 11 MC
H 
10000 5
6 
4
0 
4 10 2 4 3.53 36800 5
5 
4
3 
2 9.6 2 4 3.6 Ascari
s ova 
prsent 
PR - - 7 
 
BT – Before Treatment, AT – After Treatment, PR – Present, D.O.A – Date of Admission, D.O.D – Date of  Discharge  
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INVESTIGATION REPORTS OF BEFORE & AFTER TREATMENT FOR OP PATIENTS 
 
          BLOOD TEST   MOTION 
TEST           BT  AT  
S.NO O.P NO NAME AGE SEX TC DC HB ESR  RBC TC DC HB ESR RBC BT AT 
          Cu/mm P% L% E% gms 1/2hr 1hr Milli Cu/mm 
Cu/mm P
% 
L
% 
E
% 
gms 1/2hr 1hr Milli Cu/mm   
11 C48174 Akchaya 10 FCH 6000 45 40 15 10.1 2 4 3.5 6050 50 44 6 10.
6 
2 4  
4.0 
Ascaris 
ova  
present 
Nil 
12 D000764 Arif 9 MCH 10000 62 45 3 11 2 4 4.1 9800 62 37 1 9.8 2 2 3.5 
 
Ascaris 
ova  
present 
Nil 
13 C69239 Lokeshsingh 6 MCH 8700 49 47 4 9.8 4 10 3.8 8200 51 46 3 10 2 8 3.5 
 
Ascaris 
ova  
present 
Nil 
                       
14 D0002348 Gopika 7 FCH 8500 51 47 2 11 2 4 4.1 8350 53 46 1 12 2 4 5.1 
 
Ascaris 
ova  
present 
PR 
15 D002347 Geethapriya 8 FCH 13300 68 38 4 9 10 22 3.1 13000 68 30 2 9.8 8 16 3.6 
 
Ascaris 
ova  
present 
Nil 
16 D006794 Hariharan 12 MCH 9000 37 54 9 10.2 4 8 3.5 8700 48 50 2 10.
9 
2 4 4.1 
 
Ascaris 
ova  
present 
Nil 
17 D004893 Rakshitha 7 FCH 8500 40 56 4 9.4 2 4 3.1 8400 48 50 2 10 1 3 3.5 
 
Ascaris 
ova  
present 
Nil 
18 D00903 Krish 31/2 MCH 12000 60 48 2 9.7 4 8 3.1 10150 60 39 1 9.9 2 4 3.7 
 
Ascaris 
ova  
present 
Nil 
19 C96726 Dhivyasri 8 FCH 7300 65 33 2 10.4 2 6 3.7 7190 65 34 1 10 1 3 3.5 
 
Ascaris 
ova  
present 
Nil 
20 C95005 Harish 5 MCH 7900 54 37 9 9.9 2 4 3.5 8100 55 45 5 10.
3 
1 3 3.7 
 
Ascaris 
ova  
present 
PR 
 
BT – Before Treatment, AT – After Treatment, PR – Present 
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INVESTIGATION REPORTS OF BEFORE & AFTER TREATMENT FOR OP PATIENTS 
 
           BLOOD TEST MOTION 
TEST         
           BT AT 
S.No O.P No NAME AGE SEX TC DC Hb ESR RBC 
Milli 
Cu/mm 
TC DC Hb ESR RBC 
Mili 
cu/mm 
BT AT 
          Cu/mm P L E Gms 1/2 
hr 1hr 
Cu/mm P L E Gms 
1/2hr 1 hr    
21 C81552 Keerthika 9 FCH 6400 44 45 11 12.1 12 22 5.3 6150 48 44 2 13.5 6 12 5.1 Ascaris 
ova 
present 
  
NIL 
22 C83018 Bhuvaneshwari 8 FCH 12000 56 39 5 10.7 2 4 4.3 8000 60 38 2 13 2 2 5.1 Ascaris 
ova 
present 
  
PR 
23 C76769 kanmani 8 FCH 7600 54 36 8 10.2 4 10 3.5 8000 59 37 4 10.4 2 6 3.8 Ascaris 
ova 
present 
  
NIL 
24 C66092 pradap 4 MCH 11800 61 33 6 9.5 2 4 3.1 11600 56 42 2 12.4 1 3 4.9 Ascaris 
ova 
present 
  
PR 
25 C87939 logeshwaran 31/2 MCH 9400 40 57 3 9 2 6 3.0 9380 44 55 1 10.2 1 3 3.6 Ascaris 
ova 
present 
  
NIL 
26 C76399 Aarthy 51/2 FCH 7100 45 50 5 9.7 4 8 3.4 7000 50 48 2 10 2 4 3.5 Ascaris 
ova 
present 
  
PR 
27 C59646 Saiarun 6 MCH 10800 65 30 5 8.4 2 4 2.3 8200 65 32 3 9.2 1 3 3.1 Ascaris 
ova 
present 
  
NIL 
28 C89195 Dhanasekar 10 MCH 7200 35 60 5 9.9 2 6 3.1 7200 49 48 3 9.9 1 3 3.1 Ascaris 
ova 
present 
  
NIL 
29 C74664 Dharanipriya 3 FCH 6100 23 63 13 10.5 4 8 3.8 6100 40 52 8 10.7 2 10 4.1 Ascaris 
ova 
present 
  
NIL 
30 C88473 Arasu 3 MCH 14200 50 47 3 11.2 6 12 4.5 13000 49 50 1 12.3 2 6 5.1 Ascaris 
ova 
present 
  
NIL 
 
BT – Before Treatment, AT – After Treatment, PR –Present  
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INVESTIGATION REPORTS OF BEFORE & AFTER TREATMENT FOR OP PATIENTS 
 
     Blood test   Motion 
test 
      BT  AT  
          
S.No O.P No NAME AGE SEX TC  DC Hb ESR RBC 
 
TC DC Hb ESR Rbc BT AT 
          Cu/mm P L E Gms 
1/2hr 1hr 
Mili 
cu/mm 
Cu/mm P L E Gms 
1/2hr 1hr 
Mili 
cu/m
m   
31 C93170 Nandhini 5 FCH  10000 42 53 5 8.6 4 8 2.3 8300 60 38 2 9.6 2 4 3.5 Ascaris 
ova 
present 
  
NIL 
32 C36738 Revitha 31/4 FCH 11200 50 47 3 8.9 4 8 2.4 8300 60 38 2 11 2 4 4.1 Ascaris 
ova 
present 
  
NIL 
33 C93241 Karmugilventhan 10 MCH 6000 50 44 6 10.1 4 12 3.5 6000 58 40 2 10.5 2 6 3.9 Ascaris 
ova 
present 
  
NIL 
34 C76615 Pavithra 7 FCH 8800 44 45 11 10 4 8 3.5 8200 51 3200 7 10.2 2 4 3.6 Ascaris 
ova 
present 
  
PR 
  
35 C95255 Yuvasri 5 FCH 10700 56 40 4 9.4 4 12 3.4 8400 56 42 2 9.8 2 6 3.5 Ascaris 
ova 
present 
  
NIL 
36 C92306 Rahulkarthick 8 MCH 8600 56 40 4 10.8 4 8 3.9 8100 63 35 2 11.4 2 4 4.2 Ascaris 
ova 
present 
  
NIL 
37 C97111 Rajarajan 12 MCH 14300 65 30 5 9 2 6 3.1 13200 60 38 2 11 1 3 4.1 Ascaris 
ova 
present 
  
NIL 
38 C97369 Bhuvaneshwari 11 FCH 9600 58 39 3 10.5 4 20 3.8 8200 59 39 2 10.9 2 12 3.6 Ascaris 
ova 
present 
  
NIL 
39 B82608 Mahadevi 6 FCH 11200 66 31 3 9.9 4 12 5.1 10800 68 30 2 11.3 2 6 4.1 Ascaris 
ova 
present 
  
NIL 
40 D000877 Rethanya 31/2 FCH 11700 55 40 5 10.4 2 4 3.4 11400 58 40 2 11.6 1 2 3.4 Ascaris 
ova 
present 
  
NIL 
 
BT – Before Treatment, AT – After Treatment, PR-Present  
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Statistical Analysis: 
 
All collected data were entered into MS Excel software using different 
columns as variables and rows as patients. SPSS software was used to perform 
statistical analysis. Basic descriptive statistics include frequency distributions and 
cross-tabulations were performed. The quantity variables were expressed as Mean ± 
Standard Deviation and qualitative data as percentage. A probability value of <0.05 
was considered to indicate as statistical significance. Paired ‘t’ test was performed for 
determining the significance between before and after treatment 
 
. 
Paired Samples Statistics 
 
 Mean N Std. Deviation Std. Error Mean 
Pair 
1 
TCB 9345.00 40 2181.737 344.963 
TCA 9169.25 40 4857.811 768.087 
Pair 
2 
DCPB 49.80 40 10.678 1.688 
DCPA 55.93 40 6.314 .998 
Pair 
3 
DCLB 45.23 40 8.845 1.398 
DCLA 120.53 40 499.427 78.966 
Pair 
4 
DCEB 5.33 40 3.033 .480 
DCEA 2.48 40 1.569 .248 
Pair 
5 
HBB 9.992 40 .8538 .1350 
HBA 10.488 40 1.2327 .1949 
Pair 
6 
ESRHB 3.58 40 2.086 .330 
ESRHA 2.10 40 1.277 .202 
Pair 
7 
ESR1B 8.35 40 4.572 .723 
ESR1A 5.25 40 2.994 .473 
Pair 
8 
RBCB 3.5533 40 .65628 .10377 
RBCA 3.862 40 .5865 .0927 
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Paired Samples Test 
 
t df 
Sig. (2-
tailed) 
 
Pair 1 TCB - TCA .244 39 P=0.808 Not sig 
Pair 2 DCPB - DCPA -5.066 39 P<0.001 Sig 
Pair 3 DCLB - DCLA -.953 39 P=0.346 Not Sig 
Pair 4 DCEB - DCEA 8.459 39 P<0.001 Sig 
Pair 5 HBB - HBA -2.741 39 P<0.009 Sig 
Pair 6 ESRHB - ESRHA 7.930 39 P<0.001 Sig 
Pair 7 ESR1B - ESR1A 8.339 39 P<0.001 Sig 
Pair 8 RBCB - RBCA -3.563 39 P<0.001 Sig 
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    DISCUSSION 
 
The phytochemical analysis showed the presence of tannins and mucilaginous materials. 
Tannins are known to produce anthelminthic activity by binding to glycoproteins on the 
cuticle of the parasite. They hinder energy production in the helminthic parasite. by 
interfering with oxidative phosphorylation. KKC is found to be safe at the dose of 
2000mg/kg/po and did not exhibit any toxicity on hematopoietic system, liver and kidney 
function tests after 14 days repeated oral toxicity study. Similarly no changes were observed 
in the architecture of vital organ after 14 days treatment .KKC a herbal medicine formulation 
used to treat worm infestations in children by Siddha physicians was tested for its invitro 
anthelminthic activity and laxative activity. The test drug was evaluated for its anthelminthic 
activity using ascaris worms and the result was compared with that of Piperazine citrate, a 
well-known ascaricide used in modern practice. After paralysis of the worms using 
Piperazine citrate, the worms have to be expelled out from the intestine using a purgative. 
However the inbuilt laxative effect present in KKC will expel out the worm after paralysis or 
death. The dual actions of KKC, viz. anthelminthic and laxative actions are distinctly 
different from allopathic medicines. 
  
The siddha systems of medicine concentrate on the changes that occurs in vatham, pitham, 
kabam.These are responsible for the maintaining the normal equilibrium of the body.kudal 
kirimi is characterised by  vague  symptoms  of  abdominal pain, nausea, anorexia and 
disturbed sleep with grinding teeth. Live worms are passed in stools or through 
vomiting.Nowdays  most  of the children are affected by worm infestation due to pica,faeco-
oral route,contaminated  food and vegtables.It may be resemblance with Ascaris 
lumbricoides,according to  the definition given in the medical scientific literature. The 
treatment  commonly practising physicians are albendazole and mebendazole. 
For this study the  siddha polyherbal formulation from Brahmamuni karukadai  
soothiram - 380 text   were  chosen,Selected experimental drug  namely kudal kirumi 
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chooranam for the management of  kudal kirumi.In this  study  children  with kudal kirumi  
were enrolled in our department of kuzhandhai maruthuvam and examined the children with 
siddha diagnostic method.Before and after the coures of treatment patients were subjected to 
laboratory investigation . 
The primary challenge for achieving feasibility was the   recruitment of 40 
participants aged 3 to 12 yrs old in the specified time period.The  children  targeted for this 
study as the need to treat their kudal kirumi was perceived to be the greatest. Our findings are 
consistent with a previous report showing effectiveness in treating kudal kirumi with siddha 
formulations.Among the 40 children of both the gender 17 (42..5%) were male child and 23 
(57.5%)  were female child.There we didnt come to the conclusion , the kudal kirumi  have 
affected for particulars genders.In dietary habits,32 (80% ) were non -vegetarian and 8 (20%).   
were vegetarian.In this study 80% of Non-vegetarian children were affected due to intake of 
contaminated meat and fish varieties.In vatham abanan and samanan were affected  for all 
those children. The medicine is found to have anthelmintic and laxative activities. 
Investigations like TC, DC, ESR, Hb, and Motion analysis were taken. Motion analysis 
before treatment had shown 100% Ascaris Ova existence. After treatment 80% of cases had 
shown Nil Ascaris Ova.    
There were no adverse events attributed to the study kudal kirimi chooranam  and also 
didnt affect serum  parameters.Given the inclusion of children participants in this study, 
much care was taken to monitor adverse events experienced due to the taking of kudal kirumi 
chooranam.Our results suggest that the experimental formulation didnt have a negative 
impact on these serum parameters was not the  primary outcome of our study ,thus the study 
was not powered to evaluate the  siginificance of these results. 
As one of the common herbal medicine in the siddha system of medicine and 
accounting for more presciptions in India,the use of kudal kirumi chooranam is very easy.  
Further, the relatively good safety profile of the kudal kirumi chooranam, makes it appealing 
for self administrating by  kudal kirumi suffers.However , it is recommended that any attempt 
to use kudal kirumi chooranam in the management of kudal kirumi should be carefully 
monitored by a siddha practitioner given that ,there are still many question about the correct 
dose, its true effectiveness interactions with others condition or therapeutics and possible 
adverse reaction. 
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There are several limitation to our study kudal kirumi at  warrant discussion.The 
purpose of this study was to assess the feasibility of studying for the management of the 
kudal kirumi in a larger, blinded  randomised  controlled trial and as such this study was 
difficult designed to allow us to draw clear conclusion about  its efficacy.The sample size was 
small,thus our findings are preliminary and definite conclusion about the efficacy and safety 
of the experimental formulations difficult be made .Because  the study was open labelled not 
controlled not randomised ,it is quite likely that some of the demonstrated benefit.Our 
primary outcome measure has a degree of subjectivity associated with it. 
Being the participants were children, the parents may also have impacted the results 
as sufferers  can  respond more quickly to treatment. Despite these limitation ,estimation of 
effectivesness that can be  used to estimate a sample size for a larger study.And the results are  
compelling enough to proceed with a larger trial.This study focussed on determining the 
feasibility of a future large randomised controlled trial of kudal kirumi choornam for the 
treatment of kudal kirumi.  
Apart from anthelminthic acivity, Kudal Kirumi chooranam also has got laxative 
effect which is very beneficial for eradicating the worms from the intestine. A separate 
laxative is not required to be given to purge the dead or immobile worms from the intestine.  
The deworming effect of kudalkirumi chooranam by invitro study using Ascaris lumbricoides 
is a clear evidence of its anthelminthic acivity. 
      Given that our small study found statistically significant improvement on some 
secondary outcome measures, a large methodologically rigorous double blind  placebo 
controlled randomised clinicl trial is recommended.  
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7. SUMMARY & CONCLUSION 
A  number of drugs are avaible in the market, which have achieved improved efficacy and 
safety after incorporating the active agents in carrier system.Therefore, putting new life into 
erstwhile discarded drug molecules by transforming then into novel formulations can serve us 
vi able and cost effective alternative to the expensive and time consuming  search of newer 
alternative drugs and therapies in siddha system of medicine.Efficency of KUDAL KIRUMI 
CHOORANAM was showed to various categories. clinical outcome showed good 
improvement in 80% ,poor improvement in 20%.There was no adverse events noticed in 
throughout the study and the experimental formulations  were cost effective.During our study 
kudal kirumi chooranam didnt show any adverse events as like mebendazole,albendazole. 
 In recent time ,traditional siddha formulations  and a better knowledge of the 
physicochemical and phytochemical  properties of herbs and formulation have led to the 
development of evaluated siddha drug  delivery systems that have the potential to re- invent 
the treatments of kudal kirumi.There is hope and enthusiasm from this study ,that further 
research enhanced collaboration with researchers will bring this hitherto untapped potential to 
fruition.  
 
 
 
 
 
 
 
 
 
 
 
                            
  
100 
 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
A  STUDY  ON  KUDAL KIRUMI - NAAKKU PUCHI NOI (ASCARIASIS)  IN CHILDREN  
Form I - PATIENT SCREENING FORM 
1.  S1. No:                               2. OP/IP No:                          3. BED. No:  
 4.   NAME:                              5. AGE:                                 6. GENDER:  
7.  DATE:                         8.INFORMANT:                  9.CONTACT. NO: 
 
10.DATE OF ENROLLMENT:                                  11.DATE OF COMPLETION: 
 
a) INCLUSION CRITERIA 
1. Age: between 3-12 years 
2. Sex: Male and female child  
3. Loss of appetite 
4. Peri anal itching present 
5. Pain around the umbilicus 
6. Teeth grinding during sleep (Bruxism) 
7. Willing to give blood specimen and motion for the investigation when required 
 
  b) EXCLUSION CRITERIA: 
      1. Children below 3 yrs age 
      2 .Patients not willing to give blood and motion sample for investigation 
      3 .Enteric fever 
      4.Amoebiasis 
      5.Patient turned unwilling to continue in the course of clinical trial. 
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 c) WITHDRAWAL CRITERIA: 
      1.Sign of profuse dehydration. 
       2.Poor patient compliance. 
       3.Patient turned unwilling to continue in the  course of clinical trial. 
       4.Occurence of any adverse reaction. 
       5.Onset of explosive foul smelling diarrhoea. 
       6.Extra intestinal complication.   
 
    ADMITTED TO TRAIL :                     1.YES                     2.NO 
 
                If yes, S.No:                               1.IP                         2.OP 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
A  STUDY ON   KUDAL KIRUMI  -   NAAKKU PUCHI NOI  (ASCARIASIS) IN CHILDREN 
Form: II CONSENT FORM  
 
CERTIFICATE BY INVESTIGATOR 
 
I certify that I have disclosed all the details about the study in the terms readily understood by the 
parent.                                                                                                       
Signature………………….                                                                                                                                                                           
Date………………………                                                                                                          
Name…………………… 
 
CONSENT OF INFORMANT 
 
I have been informed to my satisfaction, by the attending physician, the purpose of this 
study,  and the nature of drug treatment and follow-up including the laboratory investigations to 
be performed to monitor and safeguard my Son/Daughter body functions. 
I am aware of my right to opt out of the trial at any time during the course of the trial 
without having to give the reasons for doing so. 
I, exercising my free power of choice, hereby give my consent to be included as a subject 
in the clinical trial of ‘KUDAL KIRUMI  CHOORANAM’  for the treatment of ‘KUDAL 
KIRUMI - NAAKKU PUCHI NOI (ASCARIASIS) in children.  
                                                                                                                                                             
 
Signature………………… 
 
Date:        Name:…………………… 
 
Place:        Relationship:……………. 
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§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ 
«§Â¡ò¾¢¾¡º ÀñÊ¾÷ ÁÕòÐÅÁ¨É, 
¦ºý¨É-47. 
 
Àð¼ §ÁüÀÊôÒ ÁÕòÐÅòÐ¨È. 
ÀÊÅõ : II 
 
Ì¼ü¸¢ÕÁ¢ §¿¡öìÌ (Ì¼ü¸¢ÕÁ¢ ÝÃ½õ  ) ÀÃ¢¸Ã¢ôÒò¾¢È¨Éì ¸ñ¼È¢Ôõ 
ÁÕòÐÅ ¬ö×. 
´ôÒ¾ø ÀÊÅõ 
¬öÅ¡ÇÃ¡ø º¡ýÈÇ¢ì¸Àð¼Ð 
¿¡ý þó¾ ÁÕòÐÅ ¬ö¨Å ÌÈ¢ò¾ «¨ÉòÐ Å¢ÀÃí¸¨ÇÔõ §¿¡Â¡Ç¢Â¢ý 
¦Àü§È¡ÕìÌ ÒÃ¢Ôõ Å¨¸Â¢ø ±ÎòÐ¨Ãò§¾ý ±É ¯Ú¾¢ «Ç¢ì¸¢§Èý. 
§¾¾¢:        ¨¸¦Â¡ôÀõ: 
þ¼õ:        ¦ÀÂ÷: 
 
§¿¡Â¡Ç¢Â¢ý ¦Àü§È¡÷ ´ôÒ¾ø ÀÊÅõ 
 
 ±ýÉ¢¼õ þó¾ ÁÕòÐÅ ¬öÅ¢ý ¸¡Ã½ò¨¾Ôõ, ÁÕó¾¢ý ¾ý¨Á ÁüÚõ 
ÁÕòÐÅ ÅÆ¢Ó¨Èô ÀüÈ¢Ôõ, þó¾ ÁÕòÐÅò¨¾ ¦¾¡¼÷óÐ ±ÉÐ ÌÆó¨¾Â¢ý 
¯¼ø þÂì¸ò¨¾ì ¸ñ¸¡½¢ì¸×õ, «¾¨Éô À¡Ð¸¡ì¸ ÀÂýÀÎõ ÁÕòÐÅ 
¬ö×ìÜ¼ô ÀÃ¢§º¡¾¨É¸û ÀüÈ¢Ôõ ¾¢Õô¾¢ «Ç¢ìÌõ Å¨¸Â¢ø ¬ö× ÁÕòÐÅÃ¡ø 
Å¢Çì¸¢ì ÜÈôÀð¼Ð. 
 ¿¡ý þó¾ ÁÕòÐÅ ¬öÅ¢ý §À¡Ð ¸¡Ã½õ ±Ð×õ ÜÈ¡Áø ±ô§À¡Ð 
§ÅñÎÁ¡É¡Öõ ±ý ÌÆó¨¾¨Â Å¢ÎÅ¢òÐì¦¸¡ûÙõ ¯Ã¢¨Á¨Â 
¦¾Ã¢ó¾¢Õì¸¢§Èý. 
¿¡ý ±ýÛ¨¼Â Í¾ó¾¢ÃÁ¡¸ §¾÷× ¦ºöÔõ ¯Ã¢¨Á¨Âì ¦¸¡ñÎ (Ì¼ü¸¢ÕÁ¢ 
ÝÃ½õ  )  ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬ö×ìÌ ±ÉÐ ÌÆó¨¾¨Â 
¯ðÀÎò¾ ´ôÒ¾ø «Ç¢ì¸¢§Èý 
 
                             ¦Àü§È¡÷ ¦ÀÂ÷ ¨¸¦Â¡ôÀõ:  
 º¡ðº¢ì¸¡Ã÷ ¦ÀÂ÷: ¨¸¦Â¡ôÀõ 
 
     
§¾¾¢: 
 
þ¼õ: 
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NATIONAL INSTITUTE OF SIDDHA 
            AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
A STUDY ON   KUDAL KIRUMI -  NAAKKU PUCHI NOI  (ASCARIASIS)  IN CHILDREN 
   FORM III –  CASE REPORT FORM 
 
1. S.No :                            2.OP/IP No:  2. Bed.No: 
 
3. Name  :     _______________________ 4. Age (Yr)  : 
 
5. Gender  : MC   FC 
 
6. Father’s Name         :  
 
7. Father’s Occupation  : 
  
8. Mother’s Name        : 
 
9. Religion : 
 
10. Monthly /Annual Income  :  
 
11. Socio Economical Level   : 
 
12. Informant     :    Mother Father  Guardian          --------------------- 
 
 
    
13. Postal Address   : 
     
     
14. Complaints and duration  :  
 
 
 
 
15. History of present illness  :  
 
 
 
 
16. Past History       :    
 
 
 
18. Family History :     1. Yes            2. No    
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19.Personal Habits:         
           
           1.Picca  :                 1.Yes                                   2. No   
 
           2.Bed wetting:        1.Yes                                   2. No  
    
           3.Thumb suckling  1.Yes                                    2.No  
 
           4.Nail bitting           1.Yes                                   2.No 
 
 
20. Food Habits:            1. Veg        2.   Non Veg                3.Mixed     
 
 
21. Immunization History     :Immunization whether given upon the national schedule 
 
                                           1.Yes                                  2. No  
                                 
 
 
GENERAL EXAMINATION: 
 
22.ANTHROPOMETRY 
 
1. Body weight (Kg) :  
 
 
2. Height (Cms) : 
 
 
3. Head circumference: 
    
 
4. Mid arm circumference: 
 
  
23.VITAL SIGNS: 
 
1. Body temperature ( F ): 
 
2. Heart rate/minute : 
 
 
 
3.Pulse rate /minute  : 
 
4. Respiratory rate/minute:  
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     1.Yes   2.No 
       
5. Pallor   : 
      
6. Jaundice   : 
 
7. Clubbing   : 
   
8. Cyanosis   : 
 
9. Pedal Oedema  : 
 
10. Lymphadenopathy : 
 
 
 
24.EXAMINATION OF ABDOMEN: 
 
1. Inspection : 
 
 
2. Palpation : 
 
 
3. Percussion : 
 
 
4. Auscultation : 
 
25.EXAMINATION OF VITAL ORGANS 
 
1. CVS :  
 
2. RS :  
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26.CLINICAL ASSESSMENT: 
 
 
              1.Yes     2.No 
       
1. Loss of appetite  :   
 
2.Pain around the umbilicus/Abdominal pain :                                
 
3.Teeth grinding during sleep(Bruxism):  
                                                      
 4 :Peri –anal itching  : 
 
 5.Fever :  
    
 6.Nausea : 
 
 7.Vomiting : 
 
 8.Constipation : 
 
 9.Disturbed sleep:  
 
10.H/O Passing worms in faeces        
                        
SPECIAL EXAMINATION: 
 
 
 
27.NILAM:  
 
1. Kurinji   2. Mullai   3.Marutham 
 
4. Neithel   5. Paalai     
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28. KAALAM:    
 
1. Kaarkalam    2.  Koothirkaalam 
 
3.   Munpanikaalam   4. Pinpanikaalam 
 
            5. Illavenirkaalam   6. Muthuvenirkaalam 
 
 
29. YAAKAI: 
1.  Vatham   2. Vatha pitham  3.VathaKabam 
 
     4.   Pitham   5. Pitha vatham  6.PithaKabam 
 
     7.   Kabam   8. Kaba vatham  9.Kabapitham 
 
29. GUNAM:   
 
1. Sathuvam   2. Rasatham   3. Thamasam  
  
30.PORI PULANGAL: 
    1. Normal  2. Affected 
                                                                                                      PORI     PULANGAL 
1.Mei                                                                                          _______    _______                                                                                      
  
2.Vaai                                                                                         _______   _______   
          
3. Kan                                                                                         _______   _______   
 
4. Mooku                                                                                    _______    _______  
         
5. Sevi                                                                                         _______    _______  
 
 
 
31.KANMENDHIRIUM / KANMAVIDAYAM 
 
1. Normal    2. Affected  
 
    KANMENDHIRIUM / KANMAVIDAYAM 
 
 1. Kai                                                                                          _______    _______ 
        
2. Kaal                       _______    _______  
3. Vaai            _______    _______ 
        
4. Eruvai           _______    _______ 
         
5. Karuvai          _______    _______  
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32.UYIR THATHUKKAL 
a)VATHAM :  1. Normal  2. Affected 
 
1. Pranan                   ______________ 
   
2. Abanan                     ______________ 
   
3. Viyanan        _______________ 
 
4. Uthanan        _______________ 
 
5. Samanan        _______________ 
 
6. Nagan        _______________ 
 
7. Koorman        _______________ 
 
8. Kirukaran        _______________ 
 
9. Devathathan       _______________ 
 
10. Dhananjeyan       
   
b)PITHAM   1. Normal  2. Affected  
 
1. Analam        _______________ 
 
2. Ranjagam        _______________ 
 
3. Saathagam        _______________ 
 
4. Alosagam        _______________ 
 
5. Prasagam        _______________ 
 
c)KABAM   1. Normal  2. Affected 
 
1. Avalambagam       _______________ 
 
2. Kilethagam                  ______________   
3. Pothagam        _______________ 
 
4. Tharpagam                   _______________ 
 
5. Santhigam        _______________ 
 
33.UDAL THATHUKKAL  1. Normal   2. Affected 
 
1. Saaram        _______________ 
 
2. Senneer        _______________ 
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3. Oon        __         ______________ 
 
4. Kozhuppu        _______________ 
 
5. Enbu        _______________ 
 
6. Moolai 
                                                                                                            _______________ 
 
7. Sukilam / Suronitham                                                                      ______________        
                                               
            
         
34.ENVAGAI THERVUGAL  
 
 
    1. Normal  2. Affected 
 
1. Naa : 1.Colour       _______________ 
 
              2.Character                                                                            ______________ 
 
              3.Sensory function                                                  _            ______________ 
 
 
2. Niram        _______________ 
 
3. Mozhi        _______________ 
 
 
4. Vizhi : 1.Co lour       _______________ 
 
                 2.Character                                                                        _______________ 
  
    
                3. Sensory function                                                             _______________ 
 
 5. Sparisam        _______________ 
 
 
6. Malam:    1. Normal   2. Affected 
 
          1.Niram  ____________ 
               
          2.  Nurai                                                                              _____________ 
            
          3. Elagal/Erugal _____________                                 
  
 4. Murai _____________ 
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7.Moothiram: 
 
   Neer kuri   1. Normal  2. Affected 
        1. Niram        _______________ 
 
        2. Edai        _______________ 
 
       3. Manam        _______________ 
 
       4. Nurai        _______________ 
 
       5. Enjal        _______________ 
 
       6. Nei kuri:         
        
1.Vatham  2.Pitham  3.Kabam    4.Thontham  
 
8. Naadi-1)Thani naadi: 
 
            1. Vatham     
 
             2. Pitham   
 
            3.Kabam  
   
 
                2)Thontha Naadi: 
                       
                         1.Vatha pitham 
 
              2.Pitha vatham 
                             
   3.Pitha kabam 
 
                         4.Kaba pitham 
                            
                 3)Mukkutra Naadi: 
                            
 
                 4)Thoda Naadi: 
 
                         1.Vatha kabam 
 
                         2.Kaba  vatham 
 
         35. DRUGS ISSUED: 
            Amount of drugs :  1. No. of Packs  ---------------------------------- 
                     10.5grams/14grams/21 grams.      
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NATIONAL INSTITUTE OF SIDDHA 
  AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
A  STUDY ON   KUDAL KIRUMI - NAAKKU PUCHI NOI  (ASCARIASIS) – IN CHILDREN 
Form IV - LABORATORY INVESTIGATIONS 
 
1. SI. No:                                              2. OP/IP No:                           3. BED. No:  
 4.   NAME:                                             5. AGE:                                 6. GENDER:  
 7.    DATE:                                             8.INFORMANT:                   9.CONTACT.NO: 
            10.  DATE OF ENROLMENT:                        11. DATE OF COMPLETION: 
 
 
I. BLOOD 
          1. TC :    (Cells/Cumm)          
2.DC (%):   N                L                        M             E                      
3ESR (mm) :    ½ hr                           1 hr 
4TRBC: 
5Hb(gm%)                                     
II URINE: 
1. Albumin :                                                    
2. Epithelial cells  :                 
3. Pus cells            : 
SPECIFIC INVESTIGATION: 
MOTION : Ova,cyst,occult blood 
( ZINC SULPHATE METHOD) 
 
.                                 
                                                    
           
          
 
Date:      Lecturer                          HOD 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
A  STUDY ON  KUDAL KIRUMI -  NAAKKU PUCHI NOI  (ASCARIASIS) – IN CHILDREN 
                    FORM  V – CLINICAL ASSESSMENT PROFORMA 
1.  SI. No:    2.OP/IP  No:                      3. BED. No:  
 4.   NAME:                                      5. AGE:                                  6. GENDER: 
 7.  DATE :                8. INFORMANT  9. CONTACT NO 
 10. DATE OF ENROLLMENT  11.DATE OF COMPLETION 
           
S.NO CLINICAL FEATURES 
(SIGNS AND 
SYMPTOMS) 
BEFORE THE 
TREATMENT 
(0 th day) 
AFTER THE 
TREATMENT 
(8 th day) 
1. LOSS OF APPETITE   
2. ABDOMINAL PAIN   
3. TEETH GRINDING 
DURING SLEEP    
(BRUXISM) 
  
4. PERI-ANAL ITCHING   
5. FEVER   
6. NAUSEA   
7. VOMITING   
8. 
 
CONSTIPATION   
9. DISTURBED SLEEP   
10. H/O PASSING WORMS 
IN FAECES 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 A STUDY ON KUDAL KIRUMI - NAAKKU PUCHI NOI  (ASCARIASIS) IN CHILDREN . 
Form VI – WITHDRAWAL FORM 
 
 
1.  OP/ IP No:                                                 2. BED No:                           3. Sl. No:  
 4.   NAME:                                                     5. AGE:                                 6. GENDER:  
7.  DATE :                          8. INFORMANT:           9. CONTACT NO: 
10. DATE OF ENROLLMENT :  11.DATE OF WITHDRAWAL: 
 
     Signature of Doctor 
FORM  - WITHDRAWAL  
 
Date of trial commencement    : 
Date of withdrawal from trial   : 
Reason(s) for withdrawal   : Yes/ No  
Long absence at reporting   : Yes/ No 
Irregular treatment     : Yes/ No 
Shift of locality     : Yes/ No 
Complication adverse reactions if any : Yes/ No 
Exacerbation of symptoms   : Yes/ No 
 Pt not willing to continue                         ;  Yes/No 
Signature of Principal Investigator    Signature of Parents/Guardian 
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¾¸Åø ÀÊÅõ 
 
§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ, 
«§Â¡¾¢¾¡º ÀñÊ¾÷ ÁÕòÐÅÁ¨É, ¦ºý¨É-47, 
Àð¼ §ÁüÀÊôÒ ÁÕòÐÅÐ¨È. 
 
 
· Ì¼ü ¸¢ÕÁ¢ §¿¡ö   ÌÆó¨¾¸¨Ç À¡¾¢ìÌõ ´÷ Óì¸¢Â §¿¡ö ¬Ìõ. 
· Ì¼ü ¸¢ÕÁ¢ §¿¡ö  Í¸¡¾ÃÁüÈ ¯½× Ó¨È¸Ç¡Öõ, àö¨ÁÂüÈ ÁÄõ ¸Äó¾      
Áñ½¢ø Å¢¨ÇÂ¡ÎÅ¾¡Öõ, Á¢Ì¾¢Â¡É þÉ¢ôÒ Å¨¸¸Ç¡Öõ ¯ñÀ¾¡Öõ       
ÅÃì  ÜÊÂ §¿¡ö. 
·  Ì¼ü ¸¢ÕÁ¢ §¿¡ö ¾¢ÕõÀ ¾¢ÕõÀ ÅÃì ÜÊÂÐ. 
 
·   Ì¼ü ¸¢ÕÁ¢ §¿¡öìÌ  ¬ÃõÀ¿¢¨ÄÂ¢§Ä§Â ¾Ìó¾ º¢¸¢î¨º «Ç¢ì¸¡¾ 
Àðºò¾¢ø Àø§ÅÚ ¯¼üÀ¡¾¢ôÒ¸Ç¡É ¦ºÃ¢Â¡¨Á, ¸Æ¢îºø, ¯¼ø «Ã¢ôÒ, 
¦ÅÙôÒ §¿¡ö ¯ñ¼¡Ìõ. 
 
·     º¢ò¾ ÁÕòÐÅ÷¸Ç¡ø ¸¡Ä¸¡ÄÁ¡¸ ¨¸Â¡ÇôÀðÎ ÅÕõ º¢Ä ÓÄ¢¨¸    
¸Ä¨Å ÁÕóÐ,  Ì¼ü ¸¢ÕÁ¢ §¿¡öìÌ º¢ÈôÀ¡¸ «ÛÀÅò¾¢ø þÕóÐ ÅÕ¸¢ÈÐ. 
· Ì¼ü¸¢ÕÁ¢ ÝÃ½õ  ,ÌÆó¨¾¸Ç¢ý Ì¼ü ¸¢ÕÁ¢ §¿¡öìÌ º¢ÈôÀ¡¸ ¬ö×         
¦ºöÂ §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉò¾¡ø ÀÃ¢óÐ¨Ã ¦ºöÂôÀðÎûÇÐ. 
·  §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉò¾¢ý ÁÕóÐ ¦ºöÓ¨È Ü¼ò¾¢ø   
þõÁÕó¾¡ÉÐ º¢òÐ ÁÕòÐÅ÷¸Ç¢ý §¿ÃÊ §ÁüÀ¡÷¨ÅÂ¢ø ¦ºöÂôÀðÎûÇÐ. 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
A STUDY ON  KUDAL KIRUMI- NAAKKU PUCHI NOI  (ASCARIASIS) IN CHILDREN 
FORM VII– DRUG COMPLIANCE   
1.  S.l. No:    2. OP/ IP No:                           3.Name:                                                   
4. Age:      5.Gender:   6.Date of Enrollment:  
7.  Date of completion: 8.Informant:    9.Reliablity:   
 
NAME OF THE DRUG  :   KUDALKIRUMI CHOORANAM 
FORM OF THE DRUG  :   Powder 
ADMINISTRATION & ADJUVANT:   HOT WATER 
DOSE & DURATION  : 3-4 years -500 mg 
                                                                        5-8years -750 mg 
                                                                        9-12 years -1.5 gm   
  
         DAYS DATE OF DRUG INTAKE     MORNING   NIGHT 
Day 1    
Day 2    
Day 3    
Day 4    
Day 5    
Day 6    
Day 7    
NO. OF DRUG PACKETS GIVEN : 
NO. OF DRUG PACKETS RETURNED:  
 
 
Signature of Principal Investigator                                       Date                                
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 
          A STUDY ON KUDAL KIRUMI NAAKKU PUCHI NOI  (ASCARIASIS) IN CHILDREN  
FORM VIII - ADVERSE REACTION  FORM 
 
1.  S.l. No:    2. OP/ IP No:                           3.Name:                                                   
4.  Age:   5.Gender:   6.Date of Enrollment:  
7.  Date of completion: 8.Informant:    9.Reliablity:   
 
Name     : 
Age       : 
Gender    : 
OPD/ IPD No    : 
Registration No   : 
Date of trial commencement  : 
Date of withdrawal from trial  : 
Description of adverse reaction : 
 
 
 
Date:      Signature of Principal Investigator 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 
 
A STUDY ON ‘KUDAL KIRUMI - NAAKKU PUCHI NOI  (ASCARIASIS) – IN CHILDREN 
FORM VIII - DIET FORM 
  
 
1.  S.l. No:    2. OP/ IP No:                           3.Name:                                                   
4.  Age:   5.Gender:   6.Date of Enrollment:  
7.  Date of completion: 8.Informant:    9.Reliablity:   
 
¯½× Àò¾¢Â Ó¨È¸û 
 
Ø Ýô Å¨¸¸û ¦¸¡Îì¸×õ. 
Ø þÉ¢ôÒ, ÒÇ£ôÒ ¦À¡Õð¸¨Ç ¾Å¢÷ì¸×õ. 
Ø Íñ¨¼ì¸¡ö,Á½Ä¢ì¸¢¨Ã §º÷ì¸×õ. 
 
 
Date:            Signature of Principal Investigator 
 
  
119 
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